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In human cells, almost 300 trans-acting factors are required for the production 
of ribosomes. Investigating the functions of individual proteins involved in the 
biogenesis of ribosomes is relevant because one third of these factors are related 
to genetic diseases and cancer.  
Williams-Beuren syndrome is a multisystem developmental disorder caused 
by the contiguous deletion of 26–28 genes from chromosome region 7q11.23. 
This genomic disorder is characterized by cardiovascular abnormalities, 
connective tissue anomalies, a characteristic neurocognitive and behavioural 
profile, growth delay, and a subtle but distinctive facial dysmorphology. The 
7q11.23 chromosome locus has a complex genomic architecture, consisting of a 
single-copy region surrounded by segmental duplications that predispose the 
region to chromosomal rearrangements, including deletions, duplications, and 
inversions. Although the mutational mechanisms that lead to the development 
of Williams-Beuren syndrome and a reciprocal duplication syndrome have been 
thoroughly investigated, it is not known how alterations to the copy number of 
individual genes contribute to the disease phenotypes. It is likely that several 
genes contribute to the phenotype and therefore it is important to study the 
cellular functions of all proteins expressed from the region 7q11.23. The gene 
that encodes the WBSCR22 protein is deleted in WBS, and studying the 
function of WBSCR22 is also relevant for cancer biology. Several works have 
demonstrated that WBSCR22 is upregulated in various types of cancers and 
regulates the survival and metastatic potential of cancer cells. 
The WBSCR22 protein contains an S-adenosyl-L-methionine binding motif 
that is present in many methyltransferases, and, prior this work, in silico 
predictions indicated that WBSCR22 is a DNA methyltransferase. Later, 
WBSCR22 was suggested to be involved in histone methylation; only recently, 
it was confirmed to act as an 18S rRNA base methyltransferase. The first part of 
this dissertation is focused on studying the function of the WBSCR22 protein in 
mammalian cells, and, revealed that WBSCR22 is important for cell growth, 
ribosome biogenesis and pre-rRNA processing. A cell line that stably expresses 
epitope-tagged WBSCR22 was generated with the aim to study the interaction 
partners of WBSCR22, revealing that WBSCR22 interacts with several pro-
teins, including the TRMT112. Subsequently, the importance of the interaction 
between WBSCR22 and TRMT112 proteins was analysed in detail. 
The second part of this dissertation is focused on analysing the protein content 
of virus-like particles (VLPs) induced by the expression of murine leukaemia 
virus (MLV) Gag protein. The results revealed that these VLPs consist of dif-
ferent groups of cellular proteins, including ribosomal proteins from both 
subunits.  
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2. LITERATURE REVIEW 
2.1. Williams-Beuren syndrome 
Williams-Beuren syndrome (WBS, also referred to as Williams syndrome; 
OMIM 194050) is a genomic disorder caused by hemizygous deletion of 26–28 
genes on chromosome region 7q11.23 (Pober, 2010). The contiguous gene 
deletion typically ranges from 1.55 to 1.84 Mb in size, but smaller and larger 
atypical deletions have also been described (Bayés et al., 2003; Ferrero et al., 
2010; Schubert, 2009). The prevalence of WBS is relatively rare and has been 
estimated to occur sporadically in 1/7,500 to 1/20,000 live births (Strømme et 
al., 2002).  
WBS is a multisystem disorder: patients usually have a subtle but distinctive 
facial dysmorphology, cardiovascular abnormalities, connective tissue anomalies, 
a characteristic neurocognitive and behavioural profile, and growth delay 
(Merla et al., 2010). The syndrome is named after two doctors, Dr. Williams 
and Dr. Beuren, who independently characterized a syndrome with specific 
facial features, supravalvular aortic stenosis (SVAS) and mental retardation in 
the 1960s (Beuren et al., 1962; Williams et al., 1961). The main facial features 
of WBS are a broad forehead, periorbital fullness, a low nasal root, a long 
philtrum, a wide mouth and full lips (Merla et al., 2010; Popowski et al., 2011).  
The prevalence of cardiovascular diseases is high (~80%) in people 
diagnosed with WBS (Eronen et al., 2002; Pober et al., 2008). The most com-
mon cardiovascular symptoms include vascular stenosis, such as SVAS or 
pulmonary artery stenosis, and hypertension, however, patients often have 
multiple problems and a lifelong assessment of the cardiovascular system is 
recommended (Lin et al., 2008). The cardiovascular phenotype of WBS is 
similar to that of familial SVAS, and both are caused by haploinsufficiency of 
the elastin gene (ELN), which leads to reduced elastin synthesis (Ewart et al., 
1993). Individuals with WBS often have endocrine abnormalities related to 
glucose metabolism, hypothyroidism, infantile hypercalcemia, hypercalciuria 
and decreased growth spurt (Pober, 2010).  
WBS causes a special neurocognitive and behavioural profile that is charac-
terized by developmental delay and mild to moderate intellectual disability with 
IQ scores typically in the range of 50 to 60 (Merla et al., 2010; Pober, 2010). 
The language development of people with WBS is below age expectations, 
however, compared to other groups that display intellectual disabilities, children 
with WBS have a higher expressive vocabulary level, albeit similar receptive 
vocabulary levels (Van Den Heuvel et al., 2016). The characteristic pattern of 
cognitive strengths and weaknesses of WBS include hypersociability, friend-
liness, and empathy towards others, but also the presence of anxieties, phobias, 
and a visuospatial construction deficit (Merla et al., 2010; Pober, 2010). 
Individuals with WBS often have strong attraction to sounds and music but on 
the other hand, they can be hypersensitive to certain noises like fireworks or 
thunderstorms (Gothelf et al., 2006; Pober, 2010). It has been shown that high 
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frequency sensorineural hearing loss has developed in ~75% of WBS adults 
over the age of thirty (Cherniske et al., 2004).  
In addition to clinical observation, a diagnosis of WBS is confirmed either 
by fluorescence in situ hybridisation analysis (FISH), using the elastin gene as a 
marker, or by other molecular biology methods, e.g., restriction fragment length 
polymorphism, microsatellite analysis or array comparative genomic hybridi-
zation (Merla et al., 2010). WBS has also been diagnosed prenatally, following 
an initial diagnosis of intra-uterine growth retardation and nasal bone hypo-
plasia (Popowski et al., 2011). 
 
 
2.2. The 7q11.23 duplication syndrome 
In addition to deletions of the WBS chromosomal region, a 1.5 Mb duplication 
in the corresponding region has also been characterized, and causes 7q11.23 
duplication syndrome (also referred to as Willams-Beuren region duplication 
syndrome; OMIM 609757) (Somerville et al., 2005). Compared to WBS, the 
phenotype of 7q11.23 duplication syndrome is less severe and the syndrome 
may be underdiagnosed (Merla et al., 2010). The milder phenotype is probably 
the reason why the first case of 7q11.23 duplication was documented much later 
(Somerville et al., 2005). Some features of the duplication syndrome are 
opposite to WBS – patients with 7q11.23 duplication do not have impaired 
visuospatial cognitive skills but have deficits in social interactions and very 
poor expressive language (Merla et al., 2010). Although it is not yet fully 
defined, the phenotype of the WBS region duplication syndrome is also 
characterized by subtle but recognizable facial features, developmental delay 
and an increase in the prevalence of autistic-like features (Pober, 2010; 
Velleman and Mervis, 2011). Abbas et al. reported that ~91% of individuals 
diagnosed with WBS locus duplication have speech delay and ~75% have at 
least one anxiety disorder (Abbas et al., 2016). Among the psychiatric features, 
social anxiety, attention deficit/hyperactivity disorder, selective mutism, autism, 
and special phobias are the most prominent (Abbas et al., 2016). The diagnosis 
of WBS duplication syndrome often occurs as the result of an untargeted 
genomic analysis method such as chromosomal microarray analysis on patients 
with autistic-like features. 
 
 
2.3. The structure of the Williams-Beuren  
syndrome chromosomal region 
The structure of 7q11.23, the WBS chromosomal region, is complex (Fig. 1A), 
and consists of a single copy region (~1.2 Mb in size) that is flanked by 
segmental duplications or low copy repeats (LCRs) (Bayés et al., 2003). Three 
large LCR sequences in 7q11.23, the centromeric, middle, and telomeric LCRs 
(ordered by their location in the chromosomal band), are composed of DNA 
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blocks termed A, B, and C (Bayés et al., 2003; Schubert, 2009). The DNA 
blocks have a length of ~10–400 bp and they display ~97% sequence identity 
within each block class, which predisposes to strand misalignment and unequal 
crossing-over in meiosis, causing deletions, duplications, and inversions 
(Stankiewicz and Lupski, 2002).  
The centromeric and middle LCR blocks in the WBS chromosomal share the 
same orientation; however, the telomeric LCRs occur in the opposite direction 
compared with the centromeric and middle LCRs, which leads to the possibility 
of deletion, duplication, or inversion events in the WBS chromosomal region 
(Fig. 1C and D) (Bayés et al., 2003). The B-cen and B-mid LCRs share the 
highest degree of sequence identity (99.6%) and therefore form the most 
frequent site of meiotic non-allelic homologous recombination (NAHR), thereby 
generating the 1.55 Mb deletion seen in ~95% of WBS patients (Bayés et al., 
2003). NAHR within A-cen and A-mid, generates a 1.84 Mb deletion, which 
occurs in ~3–5% of WBS patients, and the frequency of atypical deletions are 
even lower (~2–3% of WBS cases) (Bayés et al., 2003; Merla et al., 2010; 
Schubert, 2009). In addition to unequal meiotic crossing-over between 
homologous chromosomes (Baumer et al., 1998; Cuscó et al., 2008; Urbán et 
al., 1996), WBS deletions can also occur as a result of intrachromatid 
recombination (Fig. 1D) (Bayés et al., 2003; Cuscó et al., 2008). 
Duplications of the WBS chromosomal region arise by interchromosomal 
NAHR, but not by intrachromosomal rearrangements (Fig. 1C) (Schubert, 
2009). In addition, NAHR can cause inversions (Fig. 1E) that range between 
1.79 to 2.56 Mb, but these genomic rearrangements do not appear to affect the 
expression of genes from the WBS region (Bayés et al., 2003; Tam et al., 2008). 
Inversions can occur in meiosis or mitosis due to intrachromatid misalignment 
(Schubert, 2009).  
 
 
Figure 1. A schematic representation of the Williams-Beuren syndrome chromosome 
region (7q11.23) and chromosomal rearrangements. A) The Williams-Beuren chromo-
some region consists of a 1.2 Mb single copy gene region (blue) and highly similar low-
copy repeat (LCR) blocks A (grey), B (red), and C (black). Lower case letters  
(c-centromeric, m-medial, t-telomeric) mark the positions of LCRs within the chromo-
somal band. B) Protein-coding genes in the single copy gene region, in medial block  
C (Cm) and B (Bm) duplicons. These genes are commonly deleted in WBS patients. C) 
Development of deletion and duplication due to interchromosomal or interchromatid 
NAHR between directly oriented LCRs. Here we present the most frequent deletion and 
duplications with breakpoints in the centromeric and medial B-blocks. D) Intrachro-
matid NAHR leads to the deletion and generation of an acentric chromosome, the latter 
of which can be lost in segragation. E) Development of inversions in the WBS region 
caused by NAHR of inverted LCR blocks. Misalignment can occur between centro-
meric and telomeric blocks of type C, A, and B and therefore the size of the inverted 
region is variable. 
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2.4. The contributions of individual genes  
of the WBS locus to the clinical outcome 
Although the molecular mechanisms that lead to the development of genomic 
rearrangements in 7q11.23 have been known for many years, the role of 
individual genes to the WBS phenotype has not yet been solved. Genomic 
rearrangements in the WBS region affect the copy number of up to 28 genes 
(Merla et al., 2010; Pober, 2010). Quantitative PCR analysis from skin 
fibroblasts and lymphoblastoid cell lines of WBS patients demonstrate that the 
hemizygous deletion of 7q11.23 leads to a reduced expression of genes located 
within the deleted interval (Merla et al., 2006). Furthermore, the mRNA level of 
some genes that flank the deleted region is also decreased in these patients, 
showing that the number of genes that can influence the development of WBS 
phenotype is more numerous than previously expected (Merla et al., 2006). 
Deletion of elastin gene (ELN) is known to cause cardiovascular problems such 
as SVAS (Ewart et al., 1993), however, determining the role of many other 
genes requires further study.  
 
 
2.5. The WBSCR22 protein 
2.5.1. The structure and function of WBSCR22 protein 
One of the protein coding genes that is mapped within single copy gene regions 
of the WBS locus is WBSCR22 (Doll and Grzeschik, 2001; Merla et al., 2002). 
WBSCR22 mRNA encodes a protein composed of 281 amino acid residues 
with a predicted molecular weight of 31.8 kDa and an isoelectric point of 8.95 
(Doll and Grzeschik, 2001). The protein is conserved in eukaryotes (White et 
al., 2008). In silico analysis has shown that the WBSCR22 protein contains a 
carboxy-terminal nuclear localization signal (NLS) and an amino-terminal  
S-adenosyl-L-methionine (SAM) binding motif that is common for methyl-
transferases (Merla et al., 2002). The human genome encodes 208 methyl-
transferases that methylate nucleic acids, proteins, lipids, or small molecules, 
and the WBSCR22 protein belongs to the largest class of methyltransferases – 
seven-β-strand superfamily or “class I” methyltransferases (Petrossian and 
Clarke, 2011). The core of these enzymes is composed of seven-stranded  
β-sheets, where the first six β-sheets are parallel and the seventh occurs in the 
opposite direction (Falnes et al., 2016; Petrossian and Clarke, 2011). The β-sheets 
(ordered 3214576) are flanked by α-helices (αZ and αA-αE) – three helices (Z, 
A, B) are on one side and three helices (C, D and E) on the other (Martin and 
McMillan, 2002). The yeast orthologue of human WBSCR22 is the Bud23 
protein (Ebersberger et al., 2014). A crystal structure analysis of the methyl-
transferase domain of budding yeast Bud23 protein revealed that it contains a 
typical class I methyltransferase fold (Létoquart et al., 2014). The 50% 
sequence similarity of WBSCR22 with yeast Bud23 leads us to believe that the 
structure of WBSCR22 might be similar to the Bud23 protein. 
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Despite the presence of the methyltransferase fold, the enzymatic activity of 
WBSCR22 was unknown for a long time. Based on sequence alignment, it was 
first suggested to be a DNA methyltransferase, but so far, no DNA methyl-
transferase activity has been verified experimentally (Doll and Grzeschik, 
2001). Several studies have analysed whether WBSCR22 might be a histone 
methyltransferase (Jangani et al., 2014; Nakazawa et al., 2011). The results of a 
comparative transcriptome analysis demonstrated a negative correlation between 
WBSCR22 and tumor-supressor Zac1 expression, which suggested that 
WBSCR22 might be a protein methyltransferase that renders transcriptionally 
repressive chromatin environment (Nakazawa et al., 2011). Chromatin-immuno-
precipitation results indeed indicated the loss of H3-Lys9 methylation in the 
Zac1 promoter after the depletion of WBSCR22; however, an in vitro methyla-
tion assay could not confirm the histone methyltransferase activity of WBSCR22 
(Nakazawa et al., 2011). In addition to regulating Zac1 expression, down-
regulation of WBSCR22 expression influences the glucocorticoid receptor target 
gene GILZ1 by decreasing its response to glucocorticoid receptor induction 
(Jangani et al., 2014). WBSCR22 affects glucocorticoid receptor binding to its 
response elements and furthermore, the intact methyltransferase domain and  
S-adenosyl-methionine binding sequence of WBSCR22 is necessary to support 
glucocorticoid receptor transactivation (Jangani et al., 2014). Although the 
downregulation of WBSCR22 causes changes in the status of histone methyla-
tion in the GILZ1 promoter, the authors of the latter article could not prove that 
WBSCR22 possess histone methyltransferase activity (Jangani et al., 2014). 
We and others have shown that WBSCR22 is involved in ribosome bio-
genesis and pre-rRNA processing (Paper I; Tafforeau et al., 2013). Recently, the 
methyltransferase activity of WBSCR22 and its molecular target were con-
firmed. As with yeast Bud23, WBSCR22 carries out ribosomal RNA methyla-
tion, namely the methylation of G1639 of 18S rRNA and is one of the few 




2.5.2. The expression pattern of WBSCR22 
This gene is composed of twelve exons and spans ~45 kbp on genomic DNA 
(Doll and Grzeschik, 2001; Merla et al., 2002). Using a panel consisting of 
twenty human cDNA pools from various tissues and developmental stages, 
Merla et al detected high expression of WBSCR22 mRNA in kidney, spleen, 
liver, lung, testis, and fetal heart (Merla et al., 2002). Another study, performed 
by Doll and Grzeschik, analyzed eight human tissues and showed that WBSCR22 
mRNA was detected in all samples tested with high expression in skeletal 
muscle, heart, and kidney (Doll and Grzeschik, 2001). An analysis of human gene 
expression array data demonstrated that WBSCR22 is widely or ubiquitously 
expressed with increased expression in bronchial epithelium and activated 
immune cells – e.g., in B lymphocytes and CD8+ T lymphocytes (Jangani et al., 
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2014). Due to the observation that WBSCR22 expression is upregulated in 
primary plasma cells, Tiedemann et al. suggested that it might have a role in 
plasma cell biology (Tiedemann et al., 2012). 
The expression of WBSCR22 is upregulated in different types of cancer – in 
invasive breast cancer (invasive ductal carcinoma), hepatocellular carcinoma 
and multiple myeloma (Nakazawa et al., 2011; Stefanska et al., 2014; Tiede-
mann et al., 2012). Using a mouse experimental metastasis model, it has been 
shown that both mouse Wbscr22 and human WBSCR22 proteins are important 
for metastasis formation by regulating tumour cell survival in the mouse 
vasculature (Nakazawa et al., 2011). The metastatic potential of Wbscr22 
depends on its expression level – overexpression of Wbscr22 enhances, and 
down-regulation by shRNAs reduces the metastatic ability of cancer cells 
(Nakazawa et al., 2011). Because the expression level of WBSCR22 seems to 
affect the oncogenic potential of the cell, its expression level might be tightly 
controlled. The importance of WBSCR22 in cancer biology was further 
confirmed by the results of a high throughput siRNA screen that targeted about 
one third of the human genome. This study showed that WBSCR22 is among 57 
multiple myeloma survival genes (Tiedemann et al., 2012). Although the 
downregulation of WBSCR22 expression affects the survival of non-myeloma 
cells, as in the 293 and A549 cell-lines, the absence of WBSCR22 seems to be 
more detrimental to multiple myeloma cells (Tiedemann et al., 2012). The 
relevance of WBSCR22 for cell survival is supported by recent screens that 
employed CRISPR/Cas9 genome editing and gene trap methods to show that 
WBSCR22 is among the genes that are essential in human cells (Blomen et al., 
2015; Wang et al., 2015a). 
 
 
2.5.3. The functions of non-mammalian WBSCR22 homologs 
In the beginning of this work, the cellular function of the WBSCR22 protein was 
unknown. However, as already discussed, WBSCR22 protein is highly conserved 
in eukaryotes and the functions of some of its orthologs are better characterized. 
The budding yeast protein Bud23 is not essential, however, the deletion of 
Bud23 gene causes a slow growth phenotype (Niewmierzycka and Clarke, 1999). 
Saccharomyces cerevisiae has a bipolar budding pattern which means that it can 
divide either from its distal or proximal polar end. However, a bud23 deletion 
mutant has a random budding pattern, meaning that Bud23 is important for bud-
site selection (Ni and Snyder, 2001). In addition, Bud23 is known to be 
important for ribosome biogenesis, 18S pre-rRNA processing and for the 
formation of m7G1575 of 18S rRNA (White et al., 2008). Similarly, the Rid2 
protein in Arabidopsis thaliana’s is important for cell proliferation (Ohbayashi 
et al., 2011). Rid2 was first characterized from a genetic screen that analysed 
temperature-sensitive mutants defective in root formation (Konishi and 
Sugiyama, 2003). The Rid2 protein is involved in rRNA processing while its 
mutation leads to the enlargement of nucleoli and the accumulation of various 
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pre-rRNA processing intermediates (Ohbayashi et al., 2011). Although RID2 and 
Bud23 are both involved in rRNA processing, expression of RID2 protein does 
not correct the slow growth phenotype of bud23 mutant (Ohbayashi et al., 2011).  
 
 
2.6. Eukaryotic ribosome biogenesis 
2.6.1. The structure and function of ribosomes 
Ribosomes are large ribonucleoprotein complexes essential for translating the 
genetic information encoded within mRNAs into proteins. These particles are 
composed of ribosomal RNA (rRNA) and proteins (r-proteins): the RNA com-
ponent has catalytic activity and therefore the ribosomes are actually ribozymes. 
The eukaryotic and prokaryotic ribosomes differ in size – eukaryotes have more 
complex 80S ribosomes, whereas prokaryotes have smaller 70S ribosomes. 
Each ribosome is composed of two unequal subunits, the large subunit (LSU) 
and the small subunit (SSU) – e.g., 60S and 40S subunits in eukaryotes and 50S 
and 30S subunits in prokaryotes. The small subunit contains a decoding centre 
that monitors the complementarity between the anticodons in tRNA and the 
codons in mRNA. The large subunit contains a peptidyl-transferase centre that 
catalyses the formation of peptide bonds. Each ribosome contains aminoacyl-
tRNA, peptidyl-tRNA, and deacylated tRNA binding regions termed ribosome 
A-, P- and E-sites, respectively. In contrast with prokaryotic ribosomes, 
eukaryotic ribosomes contain additional r-proteins and additional residues in 
both protein and rRNA content, termed ribosomal protein extensions and rRNA 
expansion segments, respectively (Wilson and Doudna Cate, 2012). The 
structural core of ribosomes is highly conserved and eukaryote specific rRNA 
expansion segments (5 in SSU and 16 in LSU) and ribosomal protein extensions 
are mostly localized to the surface of ribosomal subunits (Wilson and Doudna 
Cate, 2012). The deletion experiments conducted in budding yeast indicate that 
eukaryotic expansion segments affect ribosome biogenesis and are important for 
growth (Ramesh and Woolford, 2016). 
The human 40S subunit has one rRNA (18S rRNA) and 33 proteins, whereas 
the 60S subunit has three rRNAs (28S, 5.8S and 5S rRNA) and 47 proteins 
(Anger et al., 2013). The yeast 60S subunit has 25S rRNA and 46 ribosomal 
proteins, meaning that the total number of proteins in the yeast ribosomes is 79 
(Yusupova and Yusupov, 2014). 
 
 
2.6.2. Factors required for the production of eukaryotic ribosomes 
Eukaryotic ribosome biogenesis is a complex and energy demanding process 
that begins in the nucleolus, proceeds in the nucleoplasm, and is completed in 
the cytoplasm (Woolford and Baserga, 2013). Eukaryotic ribosomes are subject 
to more complex regulation and biogenesis pathways compared with proka-
ryotes and moreover, major differences occur in ribosome biogenesis of higher 
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and lower eukaryotes (Henras et al., 2015; Woolford and Baserga, 2013). Ribo-
some biogenesis involves the synthesis of pre-rRNAs and ribosomal proteins, 
pre-rRNA processing, generation of covalent rRNA modifications – e.g., 
pseudouridylations and methylations, the assembly and transport of pre-ribo-
somal particles, as well as quality control and surveillance mechanisms (Sharma 
and Lafontaine, 2015). The production of yeast ribosomes requires more than 
200 synthesis factors and ~80 small nucleolar RNAs (snoRNAs) that transiently 
associate with pre-ribosomes at certain stages during the maturation process 
(Henras et al., 2015; Mullineux and Lafontaine, 2012; Woolford and Baserga, 
2013). In human cells, more than 200 snoRNAs guide rRNA modifications and 
pre-rRNA processing (Lestrade and Weber, 2006) and it has been shown by a 
siRNA screen that at least 286 trans-acting factors are important for pre-rRNA 
processing (Tafforeau et al., 2013). Understanding the role of individual 
ribosome biogenesis transacting factors is relevant because about one third of 
the factors are related to genetic diseases and/or cancer (Tafforeau et al., 2013).  
 
 
2.6.3. The processing of pre-rRNA in eukaryotes 
2.6.3.1. The organization of human 47S pre-rRNA and  
its processing into 45S pre-rRNA 
In human cells, the rDNA that encodes 47S pre-rRNA is tandemly repeated 
within nucleolar organizing regions (NOR) on five acrocentric chromosomes 
(chromosomes 13–15, 21 and 22) and the rDNA repeats that encode 5S rRNA 
are localized on chromosome 1 (Henderson et al., 1973; Sørensen and Fre-
deriksen, 1991). The 47S pre-rRNA is a single polycistronic transcript composed 
of three rRNAs (18S, 5.8S and 28S) and it is synthesised by RNA polymerase I 
(Pol I) in the nucleolus. In Saccharomyces cerevisiae, the RNA Pol I syn-
thesizes the 35S pre-rRNA with a general architecture similar to mammalian 
47S pre-rRNA (Henras et al., 2015; Mullineux and Lafontaine, 2012).  
The nucleolus is a non-membranous nuclear compartment that forms around 
the NOR and it is the major site for ribosome biogenesis (Raska, 2003). The 
cells of most eukaryotes, including plants, invertebrates, and anamniote 
vertebrates contain bipartite nucleoli; whereas the nucleoli of amniotic reptiles, 
birds, and mammals consist of three parts (Thiry and Lafontaine, 2005; Thiry et 
al., 2011). In the inner part of tripartite nucleolus is the electron-microscope 
transparent area, fibrillar centre (FC), that contains transcriptionally active 
rDNA, transcription factors and RNA Pol I (Derenzini et al., 2006). rRNA 
transcription occurs in the interface between the FC and the dense fibrillar 
centre, which consists of an electron-dense area that contains nascent rRNA 
transcripts and ribonucleoprotein complexes that participate in pre-rRNA 
processing and rRNA modification (Denissov et al., 2011). Maturing ribosomes, 
which consist of rRNA, ribosomal proteins and transacting factors, move 
towards the nuclear periphery to the granular component of the nucleolus 
(Boisvert et al., 2007).  
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5S rRNA, is transcribed separately by RNA polymerase III in the nucleoplasm; 
however, it forms a 5S RNP complex with ribosomal proteins RPL5 and 
RPL11, followed by binding to the pre-60S particles in the nucleolus (Ciganda 
and Williams, 2011; Pelava et al., 2016). In eukaryotes, both rRNAs are 
processed by nucleases, and, in S. cerevisiae, the exonucleases Rex1p, Rex2p, 
and Rex3p participate in the processing of the 3´ end of 5S rRNA (van Hoof et 
al., 2000).  
The overall architecture of the precursor rRNA processing pathway is con-
served through evolution (Henras et al., 2015; Mullineux and Lafontaine, 2012). 
In a series of exo- and endonucleolytic cleavages, the external (5´ETS and 
3´ETS) and internal transcribed spacers (ITS1 an ITS2) are removed from the 
primary transcript and the mature 18S, 5.8S and 28S/25S rRNAs are released 
(Eichler and Craig, 1994; Henras et al., 2015; Mullineux and Lafontaine, 2012). 
The schemes for pre-rRNA processing in human and budding yeast are 
provided in Figures 2 and 3, respectively. Pre-rRNA processing in yeast can 
occur co-transcriptionally and usually starts with cleavages within 5´ETS prior 
to ITS1 processing (Kos and Tollervey, 2010; Mougey et al., 1993). In higher 
eukaryotes, pre-RNA processing can follow alternative pathways and there is no 
evidence of co-transcriptional release of pre-40S particles (Henras et al., 2015). 
The processing of human 47S rRNA transcripts begins within 5´ETS at site 
01, mapped to the conserved region in close proximity to the box C/D snoRNA 
U3 binding region (Kass et al., 1987; Mullineux and Lafontaine, 2012). The U3 
snoRNA is required for the ribosome small subunit biogenesis and 5´ETS 
processing at sites 01 and A0 in humans (Langhendries et al., 2016) but also for 
the initial processing events in mouse (Kass et al., 1990) and yeast (Hughes and 
Ares, 1991). The human 01 cleavage can occur within two alternative sites, 
either within C414-C416 or G420-U422 (nucleotide numbering corresponds to 
the primary transcript) (Kass et al., 1987). The other processing event that 
occurs shortly after transcription, occurs within 3´ETS at site 02, thereby 
producing 45S pre-rRNA (Mullineux and Lafontaine, 2012). The human 02 site 
is located in close proximity to the 3´end of 28S rRNA, and 02 processing is 
thought to happen either concomitantly with 01 cleavage or soon after 01 





Figure 2. Pre-rRNA processing in human cells. 47S pre-rRNA, transcribed by RNA polymerase I 
in the nucleolus, is composed of mature 18S (green), 5.8S (grey) and 28S (blue) rRNA. External 
(5´ETS and 3´ETS) and internal transcribed spacers (ITS1 and ITS2) flank the sequences of 
mature rRNAs and are removed by exo- and endoribonucleolytic cleavage sites. Individual 
cleavage sites are marked with blue. The 47S pre-rRNA is cleaved at 5´ETS (site 01) and 3´ETS 
(site 02), to produce 45S pre-rRNA that can be cleaved by alternative pathways, depending if the 
next cleavage occurs within ITS1 at site 2 (major pathway) or within 5´ETS at sites A0 and 1 
(minor pathway). The cleavage at site 2 produces 30S and 32S pre-rRNA and the further 
processing of 30S within 5´ETS produces the 21S pre-RNA. In the minor pathway, the cleavage 
within 5´ETS produces 41S pre-RNA that is further cleaved at site 2 to produce 21S and 32S pre-
rRNA. The cleavages at A0 and 1 are tightly coupled; however, their uncoupling can produce 26S 
and 43S pre-rRNA (not marked on scheme). The 21S pre-rRNA is cleaved at sites C and E to 
produce 18S-E and at site 3 to produce mature 18S rRNA. The 32S pre-rRNA is cleaved at site 3´ 
to separate 12S rRNA and 28S rRNA. The 5´-3´and 3´-5´exoribonucleases are involved in the 
production of 5.8SS/L rRNA and 5´-3´exoribonucleases and are required to produce the 5´end of 
mature 28S rRNA. There are two types of 5.8S rRNA in human cells, 5.8S and 5.8L, that differing 
in size ~7–8 nucleotides. The 5´extension of 5.8SL is marked with pink. 
 
2.6.3.2. 45S pre-rRNA processing within ITS1 separates the biogenesis 
pathways of small and large ribosomal subunits 
In mammalian cells, the processing of 45S pre-rRNA is flexible and is per-
formed by alternative pathways depending if the processing at site 02 is followed 
by the cleavage within ITS1 or 5´ETS region (Hadjiolova et al., 1993). In the 
major pathway of HeLa cells, pre-45S rRNA cleavage occurs within ITS1 at 
site 2 (C6469-6476), thereby producing 30S and 32S pre-rRNAs (Idol et al., 
2007; Mullineux and Lafontaine, 2012). The 30S pre-rRNA that contains 
mature 18S rRNA is further cleaved at sites A0 (producing 26S rRNA) and at 
site 1 (producing 21S pre-rRNA) (Mullineux and Lafontaine, 2012). In the minor 
pathway, 45S rRNA cleavage first occurs within 5´ETS, at site A0 (producing 
43S pre-rRNA) and at site 1 (producing 41S pre-rRNA) (Mullineux and 
Lafontaine, 2012). The 5´ETS processing site A0, which is mapped to position 
G1643, is located between sites 01 and 1 (Rouquette et al., 2005). It has been 
shown that processing at sites A0 and 1 is tightly coupled and therefore the 26S 
and 43S pre-rRNA are present at very low amounts under normal conditions 
(Rouquette et al., 2005). However, the uncoupling of cleavages at sites A0 and 
1 cause the accumulation of 43S pre-rRNA in an aggressive breast cancer cell 
line (Belin et al., 2009). The cleavage of 41S rRNA within ITS1 at site 2 
produces 21S and 32S pre-rRNAs; the same processing intermediates were 
produced in the major pathway and therefore, the downstream processing of 
21S and 32S pre-rRNA are identical in both pathways (Mullineux and 
Lafontaine, 2012). The primary transcript contains rRNAs of both ribosomal 
subunits; however, the cleavage in ITS1 leads to the separation of the rRNA 
processing pathways of the small and large ribosomal subunits. 
 
 
2.4.3.3. The formation of mature 18S rRNA 
The processing of the 21S pre-rRNA continues with 3´-5´ exoribonucleolytic 
digestion that stops at a conserved region, termed region C (Henras et al., 2015). 
Removal of ~250 nucleotides that separate site 2 and site C, yields 21S-C rRNA 
intermediates (Henras et al., 2015). The 21S-C pre-rRNA accumulates after the 
knock-down of Rps19 (Idol et al., 2007) and ENP1/bystin (Carron et al., 2011), 
and it is also detected in normal HeLa cells, albeit at a very low level (Carron et 
al., 2011).  
In the nucleolus, further processing of 21S pre-rRNA yields the 18S-E pre-
rRNA that is exported to the cytoplasm where the final maturation of 18S rRNA 
occurs (Rouquette et al., 2005). Processing of 18S-E pre-rRNA is a multistep 
process in which the first cleavage occurs at site E, located 79 and 82 
nucleotides downstream of the 3´ end of 18S rRNA (at G5606 and G5609 of the 
47S pre-rRNA) (Preti et al., 2013). Cleavage at site E is followed by rapid  
3´-5´exoribonucleolytical trimming (Preti et al., 2013). The exosome complex, 
namely the EXOSC10/RRP6, exosome cofactors SKIV2L2 and MPP6, 
exosome core protein RRP46/EXOSC5 and MTR4 helicase, participate in the 
21 
22 
production of the 3´end of 18S rRNA (Sloan et al., 2013; Tafforeau et al., 
2013). Under normal conditions, ~70-80% of the 18S-E rRNA is found in the 
cytoplasm (Rouquette et al., 2005). The exonucleolytic processing of 18S-E 
rRNA occurs during its transport and, as a result, 18S-E pre-rRNA of various 
lengths can be detected in the nucleus and cytoplasm (Preti et al., 2013). The 
longest 18S-E rRNA variants contain more than 40 nucleotides of ITS1 and are 
predominantly localized in the nucleolus, whereas the shorter forms that contain 
between 14–24 nucleotides of ITS1 are found in the cytoplasm (Preti et al., 
2013). The presence of two pools of 18S-E pre-rRNA that differ in size by ~25 
nucleotides has also shown by others (Haag et al., 2015).  
The final maturation of 18S rRNA occurs in the cytoplasm and requires the 
cleavage at site 3, which is performed by the conserved endonuclease NOB1 
(Preti et al., 2013; Sloan et al., 2013). A recent article provides the three-
dimensional structure of human pre-40S particles at 19Ǻ resolution and notes 
the locations of ribosome biogenesis factors LTV1, ENP1/bystin, TSR1, RIO2, 
and NOB1 (Larburu et al., 2016). In this model, NOB1 is separated from the 
18S rRNA 3´end, and, in order to act at site 3, NOB1 should either change its 
position or undergo a change in conformation (Larburu et al., 2016). Alter-
natively, it has been suggested that mature 18S rRNA can be produced by 3´-5´ 
exoribonucleolytic trimming of 18S-E to site 3 (Henras et al., 2015). 
 
 
2.4.3.4. The formation of mature 28S and 5.8S rRNA 
The 5´end of 32S pre-RNA, which consists of ITS1, 5.8S rRNA, ITS2 and 28S 
rRNA, is further processed by exonucleolytic digestion (Mullineux and 
Lafontaine, 2012). ). In mouse and human cells, the 5´-3´ exonuclease XRN2, 
which is an ortholog of the Rat1 protein in budding yeast (Schillewaert et al., 
2012), is required for the production of the 5´end of 5.8S pre-rRNA (Wang and 
Pestov, 2011). As in yeast, the 5´end of human 5.8S rRNA is heterogeneous as 
seen by the presence of shorter (5.8SS rRNA) and longer forms (5.8SL rRNA) 
that differ in size by ~7–8 nucleotides (Heindl and Martinez, 2010; Morello et 
al., 2011). The ratio of 5.8SS and 5.8SL is between 60:40 to 70:30 in HeLa cells 
(Heindl and Martinez, 2010; Schillewaert et al., 2012) and does not change after 
XRN2 depletion (Schillewaert et al., 2012).  
Endonucleolytic cleavage of ITS2 at site 3´ (C7849 on the 47S rRNA) 
separates the 12S and 28S rRNA (Hadjiolova et al., 1993) and requires the 
Las1L protein in humans (Schillewaert et al., 2012). 12S pre-rRNA is further 
cleaved within ITS2 at site 4a (C6947 on the 47S rRNA), thereby producing 7S 
pre-rRNA (Farrar et al., 2008). The processing of the 3´end of human 5.8S rRNA 
requires the exosome complex and is performed via 3´-5´ exoribonucleolytic 
trimming (Schillewaert et al., 2012; Tafforeau et al., 2013). The accumulation 
of 7S pre-rRNA (~340 nucleotides in size) appear after the depletion of exo-
some components, including EXOSC2, EXOSC5, EXOSC10, SKIV2L2, and 
MPHOSPH6 (Tafforeau et al., 2013). However, depletion of EXOSC10 also 
causes the accumulation of another 5.8S rRNA intermediate, the 5.8S+40 
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(~190–200 nucleotides in size) (Schillewaert et al., 2012; Tafforeau et al., 2013). 
The final precursor of 5.8S rRNA is transported to the cytoplasm, where ERI1 
is required to remove the last few nucleotides of ITS2 by 3´-5´ exoribo-
nucleolytical digestion (Ansel et al., 2008; Schillewaert et al., 2012).  
The 3´end of 28S rRNA is generated in an early processing event, namely 
the 02 cleavage of 47S rRNA (Mullineux and Lafontaine, 2012). The vertebrate 
specific snoRNA U8 is important for ribosome 60S subunit biogenesis and its 
depletion leads to the accumulation of 3´ extended processing products (45S-L, 
43S-L, 41S-L, 36S-L and 32S-L) (Langhendries et al., 2016). As discussed 
above, the production of the 5´end of 28S rRNA requires the processing of ITS2 
by the 5´-3´exonuclease XRN2 (Wang and Pestov, 2011). In addition to 
producing mature rRNA ends, XRN2 is involved in the degradation of 5´ETS, 
ITS1, and ITS2 spacer fragments (Preti et al., 2013; Schillewaert et al., 2012). 
As with other rRNAs in mammals, the last intermediate of 28S rRNA, which is 
extended by 4–6 nucleotides at its 5´end, is transported to the cytoplasm, where 
its final maturation occurs (Mullineux and Lafontaine, 2012). 
 
 
2.4.3.5. pre-rRNA processing in the eukaryotic  
model organism budding yeast 
For decades, Saccharomyces cerevisiae has been the model organism in the 
field of eukaryotic ribosome biogenesis. This makes it important to introduce 
the main points gained from studies of budding yeast and compare these with 
human cells. The 35S pre-rRNA of budding yeast consists of 18S, 5.8S, and 
25S rRNAs that are interspersed with external and internal transcribed spacers; 
however, compared to the human 47S pre-rRNA, the spacers of 35S pre-rRNA, 
are smaller and the processing of 35S pre-rRNA generates the precursors that 
are similar, but not identical, to those of higher eukaryotes (Fig. 3) (Henras et 
al., 2015; Woolford and Baserga, 2013). In budding yeast, ~70% of nascent 
transcripts are cleaved co-transcriptionally at the early processing sites A0, A1, 
and A2, thereby generating 20S and 27SA2 pre-rRNAs while remaining pre-
rRNA transcripts, which are processed post-transcriptionally within the 90S 
pre-ribosome complex (Kos and Tollervey, 2010). Another study demonstrates 
that the frequency of co-transcriptional processing ranges from 41% to 79% and 
is dependent on the growth phase of budding yeast (Osheim et al., 2004). Co-
transcriptional processing requires the formation of the SSU processome, which 
consists of several processing factors including the core U3 snoRNP complex 
that base pairs via U3 snoRNA with sequences of 5´ETS and 18S rRNA 
(Dragon et al., 2002). These complexes are visible as terminal knobs at the 5´ 
ends of nascent pre-rRNA transcripts using cryo-electron microscopy (Miller 
and Beatty, 1969; Mougey et al., 1993; Osheim et al., 2004). The 5´ terminal 
knobs on nascent transcripts appear in most eukaryotes, however, co-transcrip-
tional separation of the precursors of the small and large subunits of the ribo-





Figure 3. Schematic representation of pre-rRNA processing in Saccharomyces cerevisiae. 
The 35S pre-rRNA consists of 18S (red), 5.8S (grey), and 25S (blue) rRNAs, flanked by 
external (5´ETS and 3´ETS) and internal transcribed spacers (ITS1 and ITS2). The 
processing sites are marked. Pre-rRNA processing can occur co-transcriptionally or 
after transcription. During post-transcriptional processing, cleavage in 3´ETS at site B0 
generates the 35S pre-rRNA that is processed by coupled digestions at A0, A1, and A2, 
yielding 20S and 27SA2 pre-rRNAs. The processing of 20S pre-rRNA continues with 
nuclear export and cleavage at site D, thereby generating mature 18S rRNA. There are 
two alternative routes for 27SA2 processing, either at site A3 followed by 5´-
3´exonucleolytic digestion to site B1S, or at B1L, yielding 27SBS or 27SBL, respectively. 
27SBS and 27SBL differ in their 5´ ends; however, their exonucleolytic digestions in 
ITS2 lead to the production of 25S rRNA and 5.8SS or 5.8SL rRNA, respectively. The 
5´extension present in 5.8SL is marked with pink.  
 
During post-transcriptional processing, the cleavage in 3`ETS at site B0 is 
performed by Rnt1 and releases the 90S pre-ribosome (Kufel et al., 1999; 
Venema and Tollervey, 1999). The initial cleavage is followed by cleavages at 
site A0 of 5´ETS and at site A1, generating the 33S and 32S pre-rRNAs, 
respectively (Venema and Tollervey, 1999). The A1 cleavage generates the 5´ 
end of mature 18S rRNA and the cleavage at site A2 in ITS1 results in the 
separation of the 32S pre-rRNA into the 20S and 27SA2 pre-rRNA molecules, 
which are the precursors of SSU and LSU (Henras et al., 2015; Mullineux and 
Lafontaine, 2012; Woolford and Baserga, 2013). Processing at sites A0, A1, and 
A2 is tightly coupled; however, their uncoupling or inhibition leads to cleavage 
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at site A3, thereby yielding aberrant 23S, 22S, and 21S pre-rRNAs that are 
probably degraded by the nucleolar surveillance pathway (Mullineux and 
Lafontaine, 2012). However, 23S pre-rRNA is detected in low amounts in wild 
type cells and can be a normal rRNA precursor (Granneman and Baserga, 
2004).  
Unlike the processing of 21S pre-rRNA in higher eukaryotes, which require 
both exo- and endonucleolytic cleavages, the processing of 20S pre-rRNA in 
budding yeast requires a single cleavage at site D, which is performed by the 
endonuclease Nob1, releasing ITS1 fragment D-A2, which is degraded by the 
5´-3´ exoribonuclease Xrn1 (Mullineux and Lafontaine, 2012). Site D corres-
ponds to site 3 in humans and in both organisms, the final processing step is 
performed in the cytoplasm by Nob1/NOB1 (Larburu et al., 2016; Lebaron et 
al., 2012; Pertschy et al., 2009; Preti et al., 2013; Sloan et al., 2013).  
The processing of 27SA2 pre-rRNA can occur in two alternative pathways 
either at site A3 or B1L (Woolford and Baserga, 2013). About 80% of 27SA2 
pre-rRNA is cleaved by MRP RNase at site A3 in ITS1 (Chu et al., 1994; 
Lygerou et al., 1996), thereby generating 27SA3, which is further trimmed by 
5´-3´ exoribonucleases Rat1-Rai1 heterodimer (Henry et al., 1994), Rrp17 
(Oeffinger et al., 2009) and Xrn1 (Henry et al., 1994) and requires the presence 
of A3 processing factors (Granneman et al., 2011). In the major pathway, 5´-3´ 
exonucleases stop at B1S, yielding the 27SBS pre-rRNA (Woolford and Baserga, 
2013). The remaining 20% of 27SA2 pre-rRNA is processed by direct cleavage 
at site B1L, producing the 27SBL (Faber et al., 2006). The processing of 27SBS 
and 27SBL is identical and the cleavage in ITS2 at site C2 separates the 
processing pathways of 5.8S and 25S rRNAs, thereby generating the 7SS/7SL 
and 26S pre-rRNAs (Woolford and Baserga, 2013). The 26S pre-rRNA is 
processed by a two-step 5′-3´ exonucleolytic digestion that includes the formation 
of 25.5S pre-rRNA, and is rapidly digested to 25S rRNA by 5´-3´ exonuclease 
Rat1 or Xrn1 (El Hage et al., 2008; Geerlings et al., 2000). The 7SS/7SL pre-
rRNA is processed to 6SS/6SL pre-rRNA by the exosome complex and is then 
transported to the cytoplasm where Ngl2 is required to produce mature 5.8S 
rRNA (Faber et al., 2006; Thomson and Tollervey, 2010). Due to the different 
pathways and processing sites, the two types of 5.8S rRNA molecules gene-
rated, the major 5.8SS and the minor 5.8SL, differ in their 5´ends by either 7 or 8 
nucleotides (Henry et al., 1994). 
 
 
2.7. rRNA modifications 
Ribosome biogenesis involves the formation of modified nucleotides in pre-
rRNA, which allows changing the biochemical and biophysical properties of 
certain nucleotides (Motorin and Helm, 2011). ~2–3% of the nucleotides in 
rRNA are modified (Sloan et al., 2016) and the majority of rRNA modifications 
are introduced already in the nucleolus (Watkins and Bohnsack, 2012). The 
most abundant posttranscriptional modifications in eukaryotes are pseudo-
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uridylation (Ψ) and ribose methylation – namely, there are 44 Ψs and 55 ribose 
methylations in the ribosome of budding yeast (Machnicka et al., 2013; Piekna-
Przybylska et al., 2008) and 95 Ψs and 106 ribose methylations in the human 
ribosome (Krogh et al., 2016). In addition, approximately ten base modifica-
tions are intoduced in rRNA. The number of modified bases in rRNA is similar 
in budding yeast and human and most, but not all, modifications are introduced 
at equivalent positions (Maden and Hughes, 1997; Piekna-Przybylska et al., 
2008; Sharma and Lafontaine, 2015). The rRNA modifications are often 
conserved and clustered at functionally important regions of the ribosome, 
namely the peptidyl transferase centre in the LSU and the decoding centre in the 
SSU as well as the A, P, and E sites of tRNA and mRNA binding, the poly-
peptide exit tunnel, and intersubunit bridges (Decatur and Fournier, 2002). 
Posttranscriptional modification of rRNA can affect the functions of the 
ribosome, most probably the efficiency and fidelity of translation (Decatur and 
Fournier, 2002; Motorin and Helm, 2011).  
For decades, it was assumed that each organism contains only one type of 
ribosome and all positions in the rRNA are always fully methylated; however, 
measuring the fraction of molecules modified at particular sites demonstrates 
that in human cells only ~2/3 of methylation sites are fully or close to fully 
methylated, and the remainder are partially methylated, thereby supporting the 
concept that ribosomes can be heterogeneous (Krogh et al., 2016). In the rRNA 
of budding yeast, 94 nucleotides, including the majority of base modifications, 
are close to fully modified, whereas 18 nucleotides are modified in less than 
85% of ribosomes (Taoka et al., 2016). In actively growing yeast cells, 
approximately 68% of adenosines at position 100 of 18S rRNA in both mono-
somes and polysomes are methylated, which shows that the ribosomes that lack 
A100 methylation are engaged in translation (Buchhaupt et al., 2014). The 
extent of 25S rRNA A100 methylation depends on the expression level of the 
guide RNA, the box C/D snoRNA snR51, which is required for introducing this 
modification (Buchhaupt et al., 2014).  
 
 
2.7.1. rRNA pseudouridylation and ribose 2´-O-methylation  
are carried out by ribonucleoprotein complexes 
In eukaryotes, the pseudouridylation and ribose methylation reactions are 
performed by small ribonucleoprotein (snoRNP) complexes, and guided by box 
H/ACA (Ganot et al., 1997; Ni et al., 1997) and box C/D snoRNAs (Kiss-
László et al., 1996), respectively. The formation of ribose methylation requires 
the addition of a methyl group to the 2´-oxygen of ribose, catalysed by a 
methyltransferase fibrillarin (FBL) in humans and by Nop1 in yeast (Tollervey 
et al., 1993). The ribose methylation reaction takes place five nucleotides 
upstream of the conserved D or D´ box of snoRNA and one box C/D snoRNA 
can guide the methylation at two alternative sites in the rRNA (Kiss-László et 
al., 1996; Maden and Hughes, 1997). The formation of Ψ occurs via iso-
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merization of uridine and is performed by Ψ synthase dyskerin in humans and 
by Cbf5 in yeast cells (Lafontaine et al., 1998a). The precise role of pseudouridine 
formation in ribosomes remains unknown, however it offers an additional 
hydrogen bond donor site and may be required to stabilize the structure and 
function of rRNA, as shown with the Ψs located in human 28S rRNA helix 69, 
which are part of the intersubunit bridge B2a (Sumita et al., 2005). 
Fibrillarin/Nop1 and dyskerin/Cbf5 belong to the box C/D and box H/ACA 
snoRNP complexes, respectively (Balakin et al., 1996). In addition to enzymes, 
the box C/D snoRNP complex is composed of RNA binding protein 
15.5K/NHPX, NOP56, and NOP58, whereas the box H/ACA snoRNP complex 
consists of RNA binding protein NHP2, GAR1, and NOP10 (Watkins and 
Bohnsack, 2012). The genes that encode the components of the snoRNP 
complexes are essential for the viability of human cells (Blomen et al., 2015) 
and their down-regulation causes defects in early steps of pre-rRNA processing 
(Tafforeau et al., 2013) 
Although variations in ribosome structure occur under normal conditions, 
differential expression of ribosome biogenesis factors, including rRNA modi-
fication enzymes, can lead to several diseases (Sloan et al., 2016; Tafforeau et 
al., 2013). The expression level of both snoRNAs and FBL are upregulated in 
different types of malignancies (Marcel et al., 2013; Martens-Uzunova et al., 
2012; Su et al., 2014) and mutations in the DKC1 are the cause of X-linked 
dysceratosis congenita, characterized by bone-marrow failure and increased 
susceptibility to cancer (Heiss et al., 1998). It has been shown using the 
xenograft model that decreasing the expression of fibrillarin reduces the 
tumorigenicity of human breast cancer cell line MCF-7 (Su et al., 2014).  
 
 
2.7.2. Stand-alone enzymes catalyse the formation  
of rRNA base modifications 
In eukaryotes, the formation of base methylation and acetylation are catalysed 
by stand-alone enzymes. The 25S rRNA of budding yeast contains six 
methylated bases, located in the peptidyl transferase centre (m1A645, m5C2870, 
and m3U2634), in the subunit interface (m1A2142 and m5C2278) and in the 
phosphostalk (m3U2843) (Sharma and Lafontaine, 2015). The 18S rRNA of 
budding yeast contains six modified bases, located in the decoding site (ac4C1773, 
m A1781ଶ଺ , and m A1782ଶ଺ ), mRNA channel (ac4C1280) and near the tRNA 
binding sites (m1acp3Ψ1191 and m7G1575) (Sharma and Lafontaine, 2015). In 
addition to performing rRNA modifications, several rRNA methyltransferases 
are also required for ribosome biogenesis and pre-rRNA processing; however, 
only the presence of these proteins, and not their catalytic activity is important 




2.7.2.1. 28S/25S rRNA methyltransferases involved  
in ribosome biogenesis 
Rrp8 of budding yeast catalyses the formation of m1A645 of 25S rRNA (Peifer 
et al., 2013), while nucleomethylin (NML) is responsible for the formation of 28S 
rRNA m1A1309 in human (Waku et al., 2016). Rrp8 is not essential, however, it 
affects the biogenesis of both ribosomal subunits (Peifer et al., 2013; Schilling et 
al., 2012) and pre-rRNA processing within ITS1 at site A2 (Bousquet-Antonelli et 
al., 2000). The methyltransferase activity of Rrp8 is not required to process ITS2, 
which indicates that the roles of Rrp8 in rRNA methylation and ribosome 
biogenesis are separated (Peifer et al., 2013). Human NML is not required for pre-
rRNA processing (Tafforeau et al., 2013), however, it is important for ribosome 
60S subunit biogenesis and its depletion supresses cell proliferation, by activating 
the p53 pathway (Waku et al., 2016). Under nutrient deficiency, NML inhibits 
rDNA synthesis and protects cells from energy deprivation-dependent apoptosis 
(Murayama et al., 2008; Yang et al., 2013).  
In budding yeast, the essential nucleolar protein Nop2/Nsun1 (de Beus et al., 
1994) is responsible for the formation of m5C2870 of 25S rRNA (Sharma et al., 
2013a). A decrease in the expression level of Nop2 (Nucleolar protein gene 2) 
leads to lengthened doubling time and defects in ribosome biogenesis (Hong et 
al., 1997). It has been shown that the presence of m5C2870 methylation is critical 
because the expression of a catalytically inactive mutant of Nop2 does not 
rescue either the growth defects, the impairment of ribosome biogenesis, nor the 
reduced amount of polysomes (Sharma et al., 2013a). However, another study 
demonstrated that a catalytically dead mutant of Nop2 rescued the growth 
defect of a ∆Nop2 yeast strain, showing that the presence of m5C2870 is not 
important for ribosome biogenesis (Bourgeois et al., 2015). Based on sequence 
alignment, the homologous protein NSUN1 (also known as p120 and NOL1) is 
considered as a putative candidate for human 28S rRNA m5C4447 modification 
(Sharma et al., 2013a). NSUN1 is not required for rRNA processing; however, 
it possesses m5C methyltransferase activity and the expression of human 
NSUN1 in a ∆Nop2 yeast strain completely restores the 25S rRNA C2870 
methylation and partially rescues its growth defect (Bourgeois et al., 2015; 
Tafforeau et al., 2013). 
In budding yeast, the nucleolar protein Bmt5 and the nucleocytoplasmic 
protein Bmt6 catalyse the formation of two m3U modifications in 25S rRNA 
(Sharma et al., 2014). Both proteins and methylated residues are conserved 
among lower eukaryotes, however, these enzymes are not essential and their 
absence does not affect ribosome biogenesis or cell growth (Sharma et al., 2014). 
The budding yeast Bmt2 introduces the m1A2142 of 25S rRNA (Sharma et 
al., 2013b) and Rcm1 catalyses the formation m5C2278 of 25S rRNA (Gigova 
et al., 2014; Sharma et al., 2013a). Both methylations lie in the subunit interface 
of budding yeast ribosomes, however, neither the presence of these enzymes nor 
the methylations are essential for cell growth (Sharma et al., 2013b, 2013a). 
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Yeast 25S rRNA m1A2142 is conserved in lower eukaryotes and a Bmt2 
deletion does not cause defects in ribosome biogenesis (Sharma et al., 2013b). 
25S rRNA m5C2278 is part of the eukaryote specific intersubunit bridge 
eB14 (Sharma and Lafontaine, 2015). In this bridge, ribosomal protein eL41 
connects the LSU and modified nucleotides in the decoding site of SSU, namely 
the ac4C1773, m A1781ଶ଺  and m A1782ଶ଺  of 18S rRNA (Sharma and Lafontaine, 
2015). Deletion of Rcm1 does not interfere with ribosome 60S subunit synthesis 
(Schosserer et al., 2015; Sharma et al., 2013a). Downregulation of Rcm1 in yeast 
and its orthologs in worms and flies lengthens the lifespan of these organisms 
and increases their resistance to different types of stress, including heat shock 
and oxidative stress (Schosserer et al., 2015). m5C2278 corresponds to 28S 
rRNA m5C3782 in humans and NSUN5/WBSCR20, a conserved protein in 
eukaryotes, is considered to be the enzyme that catalyses this reaction in human 
cells (Schosserer et al., 2015; Sharma et al., 2013a). The methyltransferase 
activity of human NSUN5 has not yet been elucidated, however, it is known to 
affect ribosome synthesis in the early steps of pre-rRNA processing (Tafforeau 
et al., 2013). 
 
 
2.7.2.2. 18S rRNA methyltransferases in ribosome biogenesis 
Dim1/DIMT1 catalyses the formation of dimethyladenosines  
in 3´ end of 18S rRNA 
In the small subunit of the ribosome, the structure of 3´ end of rRNA (either 16S 
and 18S rRNA) is highly conserved and contains two dimethylated adenosines, 
located in helix 45 (Piekna-Przybylska et al., 2008). The formation of these 
modifications is carried out by a family of methyltransferases that are present in 
all domains of life (O’Farrell et al., 2008). The Dim1 protein modifies 18S 
rRNA m A1781ଶ଺  and m A1782ଶ଺  in budding yeast (Lafontaine et al., 1995) and 
the homologous human protein DIMT1 (also known as DIMT1L and DIM1) 
(Stanchi et al., 2001) is involved in the formation of 18S rRNA m A1850ଶ଺  and 
m A1851ଶ଺  (Zorbas et al., 2015). The nucleolar proteins DIMT1 and Dim1 are 
essential for human and yeast cells, respectively (Blomen et al., 2015; 
Lafontaine et al., 1994). Downregulation of Dim1 causes severe defects in pre-
rRNA processing, at sites A1 and A2, and leads to both the upregulation of 22S 
pre-rRNA and the downregulation of 27SA and 20S pre-rRNAs and this, in 
turn, is followed by a depletion in the pool of mature 18S rRNA (Lafontaine et 
al., 1995). In HeLa cells, depletion of DIMT1 by RNA interference causes un-
coupling of cleavages within sites A0 and 1 which leads to the accumulation of 
26S and 43S pre-rRNAs (Zorbas et al., 2015). DIMT1 depletion in other human 
cell lines (WI-38, RKO and HCT116) causes the level of 26S pre-rRNA to rise 
and also leads to the accumulation of 21S and 21S-C pre-rRNAs, which results 
in a reduction of mature 18S rRNA (Zorbas et al., 2015). The expression of 
catalytically inactive Dim1/DIMT1 mutants is able to rescue defects in pre-
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rRNA processing, which demonstrates that the presence of 18S rRNA dimethy-
lation is not required for ribosome biogenesis (Lafontaine et al., 1998b; Zorbas 
et al., 2015).  
Dim1 is a nucleolar protein that binds to the pre-rRNA processing machinery 
and affects early pre-rRNA cleavages; however, it remains bound with pre-
rRNA and catalyses the modification of two m A	ଶ଺  on 20S pre-rRNA in the cyto-
plasm (Lafontaine et al., 1998b). In human cells, the formation of m A1850ଶ଺  and 
m A1851ଶ଺  within 18S rRNA occurs earlier, already in the nucleus, but after the 
cleavages that are regulated by the presence of DIMT1 (Zorbas et al., 2015). 
Delay in rRNA processing and modification events support the hypothesis that 
the presence of Dim1 and DIMT1 within pre-ribosomes might serve as a quality 
control mechanism that regulates ribosome biogenesis (Lafontaine et al., 1998b; 
Zorbas et al., 2015). 
 
Kre33/NAT10 catalyses the formation N4-acetylcytidines 
The Kre33 protein within budding yeast and the human protein NAT10 are 
important for the introduction of two N4-acetylcytidines within 18S rRNA 
(Sharma et al., 2015). In humans, the vertebrate-specific box C/D snoRNA U13 
(Tyc and Steitz, 1989) is also critical for the formation of ac4C1842 (Sharma et 
al., 2015). Expression of a catalytically inactive form of Kre33 demonstrates 
that 18S rRNA acetylation is not essential for the growth of budding yeast cells 
(Sharma et al., 2015). However, Kre33 interacts with pre-40S ribosomes and its 
presence is essential for the biogenesis of the ribosome small subunit, pre-rRNA 
processing, and cell growth (Ito et al., 2014a; Sharma et al., 2015). Kre33 affects 
the early nucleolar cleavages (at sites A0-A2), and, as with Dim1, down-
regulation of Kre33 expression leads to the accumulation of 22S pre-rRNA 
(Lafontaine et al., 1995; Sharma et al., 2015). The depletion of NAT10 causes 
morphological changes in nucleoli and leads to a slow growth phenotype (Shen 
et al., 2009), increased apoptosis (Ito et al., 2014b), and reduces the level of 18S 
rRNA precursors (21S and 18S-E pre-rRNA), which results in a decrease in the 
production of ribosome 40S subunits (Ito et al., 2014b; Sharma et al., 2015; 
Tafforeau et al., 2013).  
 
snoRNP complex and stand-alone enzymes participate in the formation  
of hypermodified residue (m1acp3Ψ) 
The hypermodified residue, m1acp3Ψ1191 of 18S rRNA is synthesized in three 
steps and requires the action of the snoRNP complex as well as stand-alone 
enzymes. The first step occurs in the nucleolus where the H/ACA snoRNP 
complex (snoRNP35) carries out a pseudouridylation reaction (Samarsky et al., 
1995). Thereafter, the methyltransferase Nep1 (Emg1) catalyses N1-methy-
lation of Ψ (Meyer et al., 2011) and in the cytoplasm, Tsr3 catalyses the transfer 
of aminocarboxypropyl (acp) to m1Ψ thereby producing m1acp3Ψ (Meyer et al., 
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2016). 18S rRNA hypermodification and the enzymes that catalyse its forma-
tion are conserved in eukaryotes and it has been shown that the H/ACA box 
snoRNP complex (contains snoRNA ACA13) and TSR3 are required for the 
formation of 18S rRNA m1acp3Ψ1248 in human cells (Kiss et al., 2004; Meyer 
et al., 2016). The results obtained from an in vitro methylation assay demon-
strate that human NEP1 is able to methylate Ψ1248 (Wurm et al., 2010). 
In budding yeast, deletion of either snR35 or Tsr3 causes minor growth 
defects (Meyer et al., 2016), while the presence of Nep1 is essential (Eschrich et 
al., 2002). Like other 18S rRNA methyltransferases, yeast Nep1 and human 
NEP1, are important for ribosome small subunit biogenesis (Eschrich et al., 
2002; Tafforeau et al., 2013). Downregulation of NEP1 expression slightly 
decreases the levels of 47S, 45S, and 41S pre-rRNAs (Tafforeau et al., 2013) 
and in another study, upregulation of 30S, 21S, and 21S-C pre-rRNAs is also 
documented (Warda et al., 2016). A missense mutation in the gene encoding 
NEP1/EMG1 (D86G) is the cause of a severe autosomal recessive disease 
known as Bowen-Conradi syndrome (BCS; OMIM 211180) (Armistead et al., 
2009). The BCS mutation does not abolish the methyltransferase activity of 
NEP1, however, it does disrupt a salt bridge which leads to protein aggregation 
(Armistead et al., 2009) and its subsequent degradation in a proteasome-
dependent manner (Warda et al., 2016). As a result, a decrease in the level of 
NEP1 protein impairs ribosome SSU maturation in BCS (Warda et al., 2016). 
TSR3 affects several steps in ribosome small subunit maturation and its 
depletion in human cells causes the accumulation of 47S and 18S-E pre-rRNAs 
(Meyer et al., 2016). As with the human phenotype, deletion of Tsr3 in budding 
yeast causes accumulation of 35S pre-rRNA as well as an increase in the level 
of the final precursor of 18S rRNA, and the 20S pre-rRNA (Meyer et al., 2016). 
Unlike most rRNA methyltransferases, the expression of catalytically inactive 
mutants of Tsr3 does not rescue the processing defects (Meyer et al., 2016). 
 
Bud23/WBSCR22 catalyses the formation of N7-methylated guanosine 
Eukaryotic 18S rRNA contains another base methylation, N7-methylated 
guanosine (m7G), which, in the three-dimensional structure of the ribosome, is 
located in the ridge between the P-site and E-site tRNAs (Sharma and Lafontaine, 
2015). The presence of a guanosine base at this location is highly conserved, and 
corresponds to G1338 in Escherichia coli, however, its m7G methylation is only 
present in eukaryotes (m7G1575 and m7G1639 in budding yeast and human 18S 
rRNA, respectively) (Piekna-Przybylska et al., 2008; White et al., 2008). Bud23 
in yeast and its human ortholog WBSCR22 catalyse these methyl transfer 
reactions (Haag et al., 2015; White et al., 2008; Zorbas et al., 2015).  
rRNA base methyltransferase Bud23 is not essential in yeast, however its 
absence leads to loss of 18S rRNA m7G1575 methylation, pre-rRNA processing 
defects, impaired ribosome small subunit biogenesis, and decreased cell growth 
(White et al., 2008). Bud23 interacts with components of the SSU processome, 
Utp2 and Utp14, but not with U3 snoRNA (Sardana et al., 2013). The loss of 
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Bud23 expression causes accumulation of the initial pre-rRNA transcript, 35S 
pre-rRNA, as well as a decrease in 27SA pre-rRNA, which demonstrates that 
the early pre-rRNA processing step of cleaving A2 within ITS1 is impaired 
(Sardana and Johnson, 2012; White et al., 2008). Furthermore, after cleavage 
within A2, Bud23 remains bound to 20S pre-rRNA (Sardana et al., 2013). 20S 
pre-rRNA accumulation upon Bud23 deletion shows that the protein is also 
engaged in late steps of 18S rRNA formation (White et al., 2008). Similarly, 
pre-rRNA processing defects occur in WBSCR22 depleted human cells (Haag 
et al., 2015; Tafforeau et al., 2013; Zorbas et al., 2015). On the other hand, the 
pre-rRNA intermediates that accumulate as a result of WBSCR22 depletion are 
not identical with those that increase after Bud23 deletion. The details of this 
process are discussed in section 5.1.3. 
 
 
2.8. Trm112/TRMT112 is an interaction partner  
for several methyltransferases 
Budding yeast Trm112 is a 15-kDa zinc-finger protein that interacts with 
several methyltransferases important for translation. This protein is conserved 
in all domains of life, however, the residues important for binding the zinc atom 
are not conserved in metazoans (Bourgeois et al., 2017a). In budding yeast, the 
interactions of Trm112 with four methyltransferases, i.e., Trm9, Trm11, Mtq2, 
and Bud23, are considered direct interactions because these proteins co-purify 
with Trm112 when they are co-expressed in bacterial cells (Figaro et al., 2012; 
Heurgué-Hamard et al., 2006; Mazauric et al., 2010). A recent review compares 
various crystal structures of Trm112-methyltransferase complexes and found 
that Trm112 interacts with its methyltransferase partners in a very similar way, 
and, methyltransferases probably compete with each other to interact with 
Trm112 (Bourgeois et al., 2017a). During binding, the β3 of the methyltrans-
ferase forms a β-zipper interaction with β4 of Trm112 and this complex 
formation buries a large hydrophobic region on the surface of both partners 
(Létoquart et al., 2014, 2015; Liger et al., 2011). 
Trm9-Trm112 and Trm11-Trm112 complexes are involved in the modi-
fication of tRNAs. Trm9-Trm112 modifies the wobble uridine (U34) of some 
tRNAs and the Trm11-Trm112 complex catalyses the formation of 2-methyl-
guanosine (m2G) at position 10 of several tRNAs (Mazauric et al., 2010; 
Purushothaman et al., 2005). The Mtq2-Trm112 complex catalyses the methyla-
tion of translation termination factor eRF1 (Heurgué-Hamard et al., 2006), 
whereas the Bud23-Trm112 complex catalyses the formation of m7G1575 
within 18S rRNA and participates in ribosome 40S subunit biogenesis In 
addition to direct interactions, co-immunoprecipitation analysis demonstrates 
that the Trm112 protein forms complexes with 25S rRNA methyltransferases 
Nop2 and Rcm1 and is bound to 27S pre-rRNA, 7S pre-rRNA, and 25S rRNA, 
which affects the biogenesis of the large ribosomal subunit (Sardana and 
Johnson, 2012). 
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2.9. Extracellular vesicles as carriers of biological 
information 
In order to facilitate intercellular communication in normal and pathophysiolo-
gical processes, cells release various particles, collectively termed extracellular 
vesicles (EVs), to the extracellular environment (Abels and Breakefield, 2016). 
EVs present a heterogeneous family of small membranous particles that ori-
ginate from either endosomes or from the plasma membrane, and these particles 
are divided into three groups – e.g., exosomes, microvesicles and apoptotic 
bodies (Kalra et al., 2012). Exosomes range from 40 to 120 nm in size, are 
produced inside multivesicular endosomes or multivesicular bodies, and their 
release occurs when these compartments fuse with the plasma membrane 
(Colombo et al., 2014). Microvesicles (50–1000 nm) are formed and released 
via budding from the plasma membrane of the cell (Colombo et al., 2014). 
EVs are complex structures that are covered with a lipid bilayer that contains 
transmembrane proteins and encloses soluble hydrophilic components derived 
from the cytosol of the donor cell (Colombo et al., 2014). These particles are 
internalized via endocytosis or membrane fusion, which enables the release of 
the contents of the particle into the recipient cell (Mulcahy et al., 2014). Cell-
derived membrane vesicles are endogenous carriers of cellular proteins, as well 
as genetic material (DNA, RNA and non-coding RNAs), lipids or sugars and 
thus, the contents of a particular EV can influence the phenotype of recipient 
cells (Yáñez-Mó et al., 2015). EVs are deregulated in cancer and the possibility 
of using EVs to deliver therapeutic cargo is being investigated (van Dommelen 
et al., 2012). Virus-like particles (VLPs) are produced by ectopic expression of 
retrovirus Gag protein and are biochemically very similar to EVs and could 
potentially be used in immunotherapy and for the delivery of therapeutic cargo.  
In order to use EVs for medical purpose, it is important to precisely know 
their contents. Mass-spectrometry based analyses have shown that exosomes 
contain specific groups of cellular proteins, some of which vary with cell type; 
whereas others are found in most exosomes regardless of cell type (Colombo et 
al., 2014).  
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3. AIMS OF THE STUDY 
Ribosome biogenesis is a complex process that, in human cells, requires at least 
284 trans-acting factors that participate in pre-rRNA processing and modi-
fication, ribosome subunit assembly and transport of pre-ribosomal particles 
(Tafforeau et al., 2013). One third of these factors are medically important 
because they are related to genetic diseases and cancer (Tafforeau et al., 2013). 
The gene encoding the WBSCR22 protein is deleted in Williams-Beuren 
syndrome and its expression is increased in cancers (Doll and Grzeschik, 2001; 
Merla et al., 2002; Nakazawa et al., 2011; Tiedemann et al., 2012). Orthologs of 
WBSCR22 – e.g., the budding yeast’s Bud23 and Arabidopsis thaliana’s Rid2 
have nucleolar functions and participate in ribosome biogenesis (Ohbayashi et 
al., 2011; White et al., 2008). The cellular functions of WBSCR22 were un-
known when this current work was undertaken and the aim of the first part of 
this dissertation is to investigate the functions of WBSCR22 protein in human 
cells.  
The specific aims of the first part of this dissertation (Papers I and II) are the 
following: 
• to compare the expression level of WBSCR22 protein in cell-lines derived 
from Williams-Beuren syndrome patients and healthy controls, 
• to define the subcellular localization of WBSCR22 protein in order to 
become closer to clarifying its functions in the cells, 
• to elucidate, whether WBSCR22 protein is important for cell growth, pre-
rRNA processing and ribosome biogenesis, 
• to determine the interaction partners of WBSCR22 protein, 
• to elucidate whether the interacting proteins influence the functions of 
WBSCR22 protein.  
 
The second part of this work includes the formation and characterization of 
MLV Gag based virus-like particles carrying melanoma antigens. These are 
chimeric enveloped VLPs, formed by outward budding at the plasma membrane 
of host cells and therefore, host proteins are always included in VLPs. The aim 
of Paper III is to study the protein content of MLV-Gag induced virus-like 
particles using mass-spectrometry. 
  
35 
4. MATERIALS AND METHODS 
Detailed descriptions of the materials and methods used in this study are 
provided in the original publications and briefly reproduced here.  
In general, the cellular functions of WBSCR22 protein were studied in 
human tissue culture cells in which the expression level of WBSCR22 was 
reduced using RNA interference. For WBSCR22 depletion, WBSCR22 siRNAs 
were transfected into cells and analysed 72 hours after transfection by various 
methods discussed below. In order to analyse the role of WBSCR22 
downregulation on cell growth, the number of siWBSCR22 treated and control 
cells was counted up to 5 days. Studying the role of WBSCR22 in ribosome 
biogenesis and pre-rRNA processing required fractionating the cells into 
cytoplasmic and nuclear fractions. The cytoplasmic lysate from siWBSCR22 
treated cells was used in polyribosome profile analysis. For pre-rRNA pro-
cessing analysis, RNA from whole cells, cytoplasmic and nuclear fractions was 
extracted and separated by agarose gel electrophoresis and the abundance of 
different 18S rRNA processing precursors were evaluated by Northern blot. 
HeLa cell lysate ultracentrifugation through a sucrose gradient, followed by 
gradient fractionation, immunoblot, and RNA analysis enabled us to estimate 
the sedimentation properties of endogenous WBSCR22 protein. Immunoblot 
analysis was used to study the expression level of WBSCR22 protein in cell-
lines derived from the Williams-Beuren syndrome patients. 
In order to investigate which proteins interact with WBSCR22, a cell line 
that stably expresses epitope tagged WBSCR22 protein was generated and then 
studied using co-immunoprecipitation analysis. For this purpose, these cells, 
together with control cells, were metabolically labelled in SILAC media and 
analysed using mass-spectrometry. The most significant interactions found by 
analysing the SILAC data were then evaluated using immunoblot analysis. 
Based on these results, the immunofluorescence analysis was used to study the 
subcellular localization of WBSCR22, TRMT112, and C1QBP. For this, the 
fluorescent fusion proteins EGFP-WBSCR22 and TRMT112-mCherry were 
expressed in order to determine the subcellular localisation of the WBSCR22-
TRMT112 complex in live cells. Both immunoblot analysis and flow cytometry 
were used to monitor the expression of ectopically expressed WBSCR22 and 
EGFP-WBSCR22, respectively. Treatment with a 26S proteasome inhibitor 
(MG132) followed by immunoblot or flow cytometry enabled us to analyse 
whether the expression WBSCR22 is regulated by proteasomes.  
In order to produce MLV Gag based VLPs, the mouse fibroblast cell line 
COP5 was transfected with either plasmids that encode the MLV Gag protein to 
produce MLV Gag VLPs, or with plasmids that encode both the MLV Gag protein 
and the melanoma antigen (MART1, TRP1, MAGEA4, MAGEA10 or MCAM), 
to produce VLPs that carry one of the melanoma antigens. The VLPs were puri-
fied from cell culture media and characterized using various methods. To study 
the protein content of MLV Gag VLPs and VLPs that carry melanoma antigens, 
fractions that contain the VLPs were pooled and studied using mass-spectrometry. 
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5. RESULTS AND DISCUSSION 
5.1. WBSCR22 protein is required for cell growth,  
ribosome small subunit biogenesis and pre-rRNA 
processing (Papers I and II) 
5.1.1. The level of WBSCR22 protein is reduced  
in cell lines derived from Williams-Beuren syndrome patients 
WBSCR22 is one of the genes expressed from the single-copy gene region of 
Williams-Beuren syndrome chromosome locus (Doll and Grzeschik, 2001; 
Merla et al., 2002). Expression of most of the transcripts encoded by the 
7q11.23 chromosome region, including WBSCR22 mRNA, is reduced in WBS 
patients (Merla et al., 2006). However, for two genes, dosage-compensation 
mechanisms are known to exist, and their mRNA levels remain unaffected 
compared to healthy controls (Merla et al., 2006). Crucially, the existence of 
possible compensatory mechanisms acting at the protein level remains largely 
unexplored. To analyse the expression level of WBSCR22 protein, the immuno-
blot analysis from lymphoblastoid cell lines (LCL) derived from Williams-
Beuren syndrome patients, was performed (Paper I, Fig. 6A). This analysis 
demonstrates that the expression level of WBSCR22 protein is reduced to a 
level similar to the level of mRNA found in cell lines derived from WBS 
patients, which indicates that WBSCR22 is a dosage-sensitive gene and there-
fore studying its role in human cells is of great interest. 
 
 
5.1.2. WBSCR22 depletion reduces cell growth 
Several works have shown that the mRNA of WBSCR22 is upregulated in 
different types of malignancies, including invasive breast cancer, hepatocellular 
carcinoma, and multiple myeloma (Nakazawa et al., 2011; Stefanska et al., 
2014; Tiedemann et al., 2012). In cancer cells, the expression level of WBSCR22 
regulates cell survival and metastatic potential (Nakazawa et al., 2011; Tiede-
mann et al., 2012). In the cell lines derived from WBS patients, the levels of 
WBSCR22 mRNA (Merla et al., 2006) and protein (Paper I, Fig. 6) are reduced. 
The gene-dosage of multiple genes is altered in microdeletion syndromes (such 
as WBS) and also in malignancies, and one way to understand the function of 
individual genes is to observe cells deficient in the gene of interest. To determine 
the role of WBSCR22 in regulating cell growth, RNA interference (RNAi) was 
used to silence the expression of the WBSCR22 gene in HeLa cells, and cell 
growth was monitored for 5 days (Paper I, Fig. 1B). Surprisingly, when com-
pared to control cells, the cells transfected with siRNA targeting WBSCR22 
mRNA displayed significantly reduced growth at 72, 96, and 120 hours after 
transfection. The doubling time of control cells was 21 hours, whereas in 
WBSCR22-depleted cells, the doubling time was lengthened to 25 hours. This 
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clearly demonstrates that WBSCR22 is important for cell growth. This obser-
vation is in accordance with the results obtained by gene-trap mutagenesis and 
CRIPR/Cas9-directed gene editing systems that both demonstrate that WBSCR22 
is essential for cell viability under laboratory experimental conditions (Blomen 
et al., 2015; Wang et al., 2015a). In comparison, the budding yeast protein 
Bud23, which is an ortholog of WBSCR22, is not essential for cell viability, yet 
the deletion of Bud23 causes a slow-growth phenotype (White et al., 2008). 
Similarly, in Arabidopsis thaliana, the presence of the WBSCR22 ortholog 
RID2 is required for plant growth (Ohbayashi et al., 2011). Therefore, as with 




5.1.3. WBSCR22 is required for ribosome small subunit  
biogenesis and pre-rRNA processing 
In order to determine whether human WBSCR22 affects ribosome biogenesis, 
its expression was reduced by siRNAs and a polyribosome profile analysis of 
cytoplasmic extracts was performed. As shown in Paper I, Fig. 2A, down-
regulation of WBSCR22 causes defects in ribosome small subunit biogenesis 
that are characterized by a decrease in the amount of free 40S subunits in the 
cytoplasm, together with an increase in the amount of free 60S subunits. This 
ribosome subunit imbalance results in a diminished amount of 80S ribosomes in 
WBSCR22 depleted cells, compared to control cells. This, in turn, can reduce 
the capability to translate and may be the main cause of increased cell doubling 
time (Paper I, Fig. 1A). Compared to controls, the amount of mature 18S rRNA 
decreases in the cytoplasm of WBSCR22 depleted cells, and the decreased ratio 
of 18S to 28S rRNA (Paper I, Fig. 2B) indicates that the observed defects in 
ribosome small subunit biogenesis may arise due to errors in the production of 
mature 18S rRNA.  
Mature 18S rRNA is produced from 47S pre-rRNA transcript by exo- and 
endoribonucleolytic cleavages in a complex and hierarchical pre-rRNA pro-
cessing pathway (Henras et al., 2015; Mullineux and Lafontaine, 2012). In 
human cells, at least 286 proteins affect pre-rRNA processing (Tafforeau et al., 
2013). With the aim to analyse the role of WBSCR22 in pre-rRNA processing, 
cells transfected with siRNAs against WBSCR22 were fractionated into cyto-
plasmic and nuclear parts, and the RNA from each fraction as well as whole 
cells was analysed by Northern blot (Paper I, Fig. 3B and C). In this experiment, 
a oligonucleotide probe that hybridizes to the 5´ end of ITS1 and recognizes 
18S rRNA processing precursors, including 45S, 41S, 30S, 21S and 18S-E pre-
rRNAs, was used. As depicted in Paper I (Fig. 3B and C), WBSCR22 does not 
affect the early pre-rRNA processing events because the relative amount of 45S, 
41S and 30S pre-rRNAs remained unaffected in the HeLa and HEK293 cells 
used in this study. However, when the amount of WBSCR22 was depleted, a 
slight decrease in 21S pre-rRNA occurs in the cell nucleus, together with a  
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3-fold accumulation of 18S-E pre-rRNA. This indicates that WBSCR22 is 
involved in late nuclear steps of pre-rRNA processing. Accumulation of 18S-E 
pre-rRNA upon WBSCR22 depletion was also uncovered in a siRNA screen 
that analysed the involvement of nucleolar proteins in pre-rRNA processing 
(Tafforeau et al., 2013) and later in other articles (Haag et al., 2015; Zorbas et 
al., 2015).  
18S-E pre-rRNA is the final precursor of 18S rRNA that appears in the 
nucleus, and is then exported to the cytoplasm where the final maturation of 
pre-40S subunits take place (Henras et al., 2015; Mullineux and Lafontaine, 
2012; Rouquette et al., 2005). In whole cell extract, the accumulation of 18S-E 
pre-rRNA does not indicate, whether the late nuclear processing events, or 
subsequent cytoplasmic cleavage at site, 3 is impaired. In WBSCR22 depleted 
cells, the diminished amount of free 40S particles and the nuclear accumulation 
of 18S-E pre-rRNA indicate that WBSCR22 can be important for ribosome 
small subunit export. Alternatively, the effect can be indirect, and instead of 
influencing transport to the cytoplasm, defective pre-40S particles can become 
trapped in the nucleus and accumulate. In mammalian cells, 18S-E pre-rRNA is 
comprised of mature 18S rRNA with an additional ~15 to 80 nucleotides of 
ITS1 sequence at its 3´ end (Haag et al., 2015; Preti et al., 2013; Rouquette et al., 
2005). This variation in ITS1 sequence length arises because 18S-E pre-rRNA 
processing is performed by 3´-5´ exoribonucleolytic trimming that occurs during 
the transport of pre-40S particles (Preti et al., 2013). As a result of WBSCR22 
depletion, the average length of 18S rRNA 3´ end extensions increases, which 
indicates that WBSCR22 is required for proper 3´-5´ trimming of 18S-E pre-
rRNA prior to its export to the cytoplasm (Haag et al., 2015).  
The expression of exogenous WBSCR22 is able to rescue the pre-rRNA 
processing defect present in WBSCR22 siRNA treated cells because the accu-
mulation of 18S-E pre-rRNA disappears at an expression level similar to the 
endogenous protein (Paper I, Fig. 3D and E).  
WBSCR22 is a methyltransferase that catalyses the formation of 18S rRNA 
m7G1639 methylation; however, as with the wild-type protein, it has been 
shown that the expression of catalytically inactive mutants, WBSCR22-G63E 
and WBSCR22-D82K, also rescue the ribosome biogenesis defect which 
implies that WBSCR22 protein also has a methyltransferase activity-independent 
role in ribosome biogenesis (Haag et al., 2015; Zorbas et al., 2015). Likewise, 
the methyltransferase activity of the budding yeast protein Bud23 is not critical 
for pre-rRNA processing because the exogenous expression of catalytically 
inactive forms of Bud23 rescues the pre-rRNA processing defects and the slow-
growth phenotype of a Bud23∆ yeast strain (White et al., 2008). Similarly, the 
rRNA methyltransferase activities of human DIMT1 as well as yeast Dim1 and 
Emg1/Nep1 are dispensable for ribosome biogenesis and cell growth (Lafon-
taine et al., 1995; Leulliot et al., 2008; Zorbas et al., 2015). Thus, rRNA methyl-
transferases often have two independent roles in ribosome biogenesis, and their 
participation in pre-rRNA processing seems to be more critical than their 
enzymatic activity as rRNA methyltransferases. Nevertheless, evolution has 
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maintained the catalytic activity of enzymes that modify rRNA, and rRNA 
modifications are clustered at functionally important regions of the ribosome, 
thereby implying that they are beneficial for the function of ribosomes (Decatur 
and Fournier, 2002). 
 
 
5.1.4. WBSCR22 sediments with ribosome 40S subunits 
To both perform 18S rRNA G1639 methylation and participate in pre-rRNA 
processing, WBSCR22 should bind to pre-ribosomes. Therefore, the sedi-
mentation behaviour of WBSCR22 protein in sucrose density gradient ultra-
centrifugation was analysed (Paper I, Fig. 5B and C). The results of this 
experiment revealed that WBSCR22 sediments at positions that correspond to 
ribosome 40S/pre-40S subunits. However, it did also sediment in fractions 
smaller than 40S subunits, which indicates that WBSCR22 is not exclusively 
associated with ribosomal particles. Compared to WBSCR22, Bud23 exhibits a 
broader sedimentation profile, namely in peaks corresponding to 40S/pre-40S 
and 80S/90S sized fractions (Figaro et al., 2012; Létoquart et al., 2014; Sardana 
and Johnson, 2012). The 90S pre-ribosome or SSU processome represents an 
early ribosome biogenesis complex that consists of pre-rRNA, U3 snoRNA, 
early binding transacting factors and ribosomal proteins (Dragon et al., 2002; 
Grandi et al., 2002). Bud23 sedimentation at 90S pre-ribosomes is in agreement 
with the genetic and physical interaction between Bud23 and SSU processome 
components Utp2 and Utp14 (Sardana et al., 2013). It has been proposed that 
Bud23 acts at the transition between the early and middle stages of 40S subunit 
synthesis at the time of A2 cleavage, which separates the biogenesis pathways of 
LSU and SSU in budding yeast (Sardana et al., 2013). In contrast, WBSCR22 
depletion affects processing events that occur after the cleavage within ITS1, 
which may explain why it does not sediment in large pre-ribosome fractions 
(Paper I, Fig. 3B and C). 
 
 
5.1.5. WBSCR22 is a nuclear protein that  
can accumulate within nucleoli 
The subcellular localization analysis of WBSCR22 in HeLa cells demonstrates 
that endogenous WBSCR22 exhibits a diffuse signal throughout the cell nucleus 
and it is neither accumulated nor excluded from the nucleoli (Paper I, Fig. 5A). 
A similar pattern of WBSCR22 staining is also reported for the human melanoma 
cell line A375M (Nakazawa et al., 2011). However, in some works, WBSCR22 
displays a nuclear and cytoplasmic staining with enrichment in the nucleus 
(Jangani et al., 2014; Zorbas et al., 2015). WBSCR22 contains a C-terminal 
nuclear localization signal in addition to its N-terminal methyltransferase 
domain (Doll and Grzeschik, 2001; Merla et al., 2002), and probably moves 
through nuclear pore complexes (NPC) by active carrier-mediated transport 
(Marfori et al., 2011). In addition, because of its small size (~32 kDa), WBSCR22 
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can also enter the nucleus by passive diffusion (Marfori et al., 2011). Small 
variations in the results of indirect immunofluorescence analyses can be 
explained by the properties of the antibodies used – different antibodies can 
either recognize different epitopes of WBSCR22, or, furthermore, antibodies 
can also be unspecific and bind to epitopes of other proteins. One alternative to 
immunofluorescence analysis is to take advantage of recombinant proteins 
composed of an in-frame fusion between a fluorescent protein, such as EGFP, 
and the protein of interest. The use of fluorescent fusion proteins enables one to 
study the localisation of proteins and protein complexes in live cells. As seen in 
live cell microscopy analysis (Paper II, Fig. 3A), the fusion protein EGFP-
WBSCR22 can be detected in the nucleoplasm as well as in nucleoli. The C-
terminal domain of WBSCR22 (EGFP-WBSCR22-CTD), which contains the 
NLS, can be detected in both the nucleus and nucleoli. In contrast, the methyl-
transferase domain of WBSCR22 (EGFP-WBSCR22-MTD), which lacks the 
NLS, is enriched in the cytoplasm. The nucleolar accumulation of WBSCR22 
indicates that WBSCR22 is probably involved in both nucleolar as well as 
nucleoplasmic processes. In Sacchamyces cerevisiae, Bud23-GFP localizes 
mainly in the nucleolus (White et al., 2008). Compared to WBSCR22, the 
nucleolar accumulation of Bud23 is more pronounced and corresponds with its 
involvement in earlier pre-rRNA processing steps (Sardana et al., 2013; White 
et al., 2008). In Arabidopsis thaliana, RID2-GFP expressed from the RID2 
promoter localizes in the nucleus with accumulation in the nucleolus, which is 
in accordance with its role in early and intermediate pre-rRNA processing steps 
(Ohbayashi et al., 2011). 
 
 
5.2. A principal interaction partner of WBSCR22  
in human cells is TRMT112 (Paper II)  
5.2.1. WBSCR22 interacts with TRMT112 
For a better understanding of the cellular functions of WBSCR22, it is 
important to know its interaction partners. In order to investigate the protein 
complexes that contain WBSCR22, a SILAC (stable isotope labelling by amino 
acids in the cell culture) coupled co-immunoprecipitation analysis followed by 
identification by mass-spectrometry was performed. For this experiment, cells 
that stably express BPV1 E2-tagged WBSCR22 were generated from the U2OS 
cell line. As seen in Paper II, Fig. 1A, the expression level of epitope-tagged 
WBSCR22 in the U2OS-E2Tag-WBSCR22 cell line is similar to the endo-
genous protein, which enables one to study its function close to the physiolo-
gical expression level. The same cell line was used for co-immunoprecipitation 
analysis and here the intensity ratio of heavy to light peptides reflects the 
relative abundance of peptides enriched in WBSCR22 pull-down fraction 
compared to control. 
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As seen in Fig. 1C within Paper II, the peptides of ribosomal proteins, as well 
as YBX1 (Y-box binding protein 1), C1QBP (complement C1q binding protein), 
TRMT112 (tRNA methyltransferase 11–2 homolog (S. cerevisiae)) and 
WBSCR22 itself were enriched in WBSCR22 pull-down fractions. C1QBP is a 
multifunctional protein involved in the complement pathway (Ghebrehiwet et 
al., 1994), mRNA splicing (Petersen-Mahrt et al., 1999), transcription regulation 
(Chattopadhyay et al., 2004), apoptosis (Itahana and Zhang, 2008) and also pre-
rRNA processing (Yoshikawa et al., 2015). C1QBP localizes mainly in the 
cytoplasm and mitochondria; however, a fraction of this protein is found in 
nucleoli, where it interacts with proteins involved in ribosome biogenesis, 
including FBL and NOP52, and affects the early steps in pre-rRNA processing 
(Yoshikawa et al., 2011). Although WBSCR22 is involved in the late steps of 
pre-rRNA processing, the enrichment of C1QBP in WBSCR22 pull-down 
fractions suggests that WBSCR22 might also associate with 90S pre-ribosomes. 
The interaction between C1QBP and WBSCR22 has been detected in another 
mass-spectrometry based analysis (Zhang et al., 2013), but could not be con-
firmed by immunoblot analysis, which may reflect the transient nature of this 
interaction (Paper II, Fig. 1D). C1QBP interacts with and regulates the activity 
of YBX1 (Wang et al., 2015b), another protein found in the current study. 
Although the interaction between WBSCR22 and YBX1 proteins was not 
analysed by immunoblotting in this work, its importance for ribosome bio-
genesis needs to be evaluated in future studies.  
TRMT112 exhibits the highest enrichment (H/L ratio) in the WBSCR22 
pull-down fraction (Paper II, Fig. 1C) and is also confirmed as a WBSCR22 
interacting protein by immunoblot analysis (Paper II, Fig. 1B). In agreement 
with the results of this work, another study that investigated the interaction 
partners of over-expressed WBSCR22 by mass-spectrometry also identified 
C1QBP, YBX1, and TRMT112 in WBSCR22 pull-down fractions (Jangani et 
al., 2014). The budding yeast ortholog of TRMT112, Trm112, is a small zinc-
finger protein (~15 kDa) that interacts with several methyltransferases, 
including the tRNA methyltransferases Trm9 and Trm11 (Purushothaman et al., 
2005; Studte et al., 2008), the protein methyltransferase Mtq2 (Heurgué-
Hamard et al., 2006) and the rRNA methyltransferases Nop2 and Rcm1 (Sardana 
and Johnson, 2012). Human TRMT112 protein also interacts with methyltrans-
ferases involved in translation, namely with ALKBH8 (ABH8) and HEMK2α, 
which methylate the wobble uridine of certain tRNAs and the translation 
termination factor eRF1, respectively (Figaro et al., 2008; Fu et al., 2010). Thus, 
in complex with various methyltransferases, budding yeast Trm112 and human 
TRMT112 serve as cofactors. Notably, the interaction between WBSCR22 and 
TRMT112 is required for pre-rRNA processing as well as facilitating the 18S 






5.2.2. TRMT112 regulates the stability of WBSCR22 
In order to study the functional importance of the protein-protein interactions 
revealed in this work, the expression levels of WBSCR22, TRMT112, and 
C1QBP were reduced by siRNAs, and the efficiency of depletion was determined 
by immunoblotting. As seen in Fig. 2A within Paper II, the expression of all 
proteins analysed was reduced upon treatment with their respective siRNAs. 
Furthermore, transfection with siRNA that targets TRMT112 reduced the 
expression level of TRMT112 itself and also decreased the expression level of 
WBSCR22 protein in HeLa cells. This indicates that the presence of TRMT112 
is important for the stability of WBSCR22 protein. In contrast to TRMT112 
depletion, downregulation of C1QBP expression by RNA interference did not 
alter the expression level of WBSCR22. In order to determine if the decrease in 
WBSCR22 protein level is specific to a reduced level of TRMT112 protein 
rather than an off-target effect of the particular siRNA sequence, alternative 
siRNA sequences that target TRMT112 mRNA were designed and used in a 
comparable study. As with the original TRMT112 siRNA, other siRNA 
sequences were effective in decreasing the TRMT112 mRNA expression level 
and all led to a decrease in WBSCR22 expression in the human cell lines HeLa 
and U2OS (Paper II, Fig. 2B and C). In addition, in the African green monkey 
cell line COS-7, siRNAs that target TRMT112 also reduce the expression of 
both TRMT112 and WBSCR22 (Paper II, Fig. 2D).  
siRNAs complementary to the 3´ untranslated region (3´UTR) of human 
TRMT112 mRNA decrease the expression of endogenous TRMT112; however, 
these siRNAs do not target exogenously expressed TRMT112 that lacks the 
native 3´UTR, which makes it possible to perform rescue experiments. In 
complementation analysis, the expression of exogenous TRMT112 is able to 
restore the normal protein level of WBSCR22 in cells where the expression of 
endogenous TRMT112 is silenced by siRNA transfection (Paper II, Fig. 2E). 
These results reveal that the expression level of WBSCR22 protein is positively 
regulated by the expression of TRMT112 and indicate that the availability of 
TRMT112 is crucial for the stability of WBSCR22.  
Unpublished results from our research group demonstrate that in Escherichia 
coli, recombinant histidine-tagged WBSCR22 protein is insoluble and forms 
inclusion bodies. On the other hand, co-expression of WBSCR22 and its inter-
action partner TRMT112 increases the solubility of WBSCR22 in bacterial cells 
which implies that TRMT112 regulates folding and thereby the stability of the 
WBSCR22 protein (Zorbas et al., 2015). Similarly, the budding yeast Bud23, 
Mtq2, and Trm9 proteins are largely insoluble in E. coli, and the co-expression 
of these methyltransferases with Trm112 increases their solubility (Figaro et al., 
2012; Heurgué-Hamard et al., 2006; Mazauric et al., 2010). Crystal structure 
analysis has revealed that Bud23 interacts with Trm112 through the formation 
of a parallel β-zipper involving the Bud23 strand β3 and the Trmt112 strand β4, 
thereby covering the hydrophobic residues of Bud23 (Létoquart et al., 2014). 
Thus, shielding the hydrophobic amino acid residues of Bud23 increases the 
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solubility and stability of this protein (Létoquart et al., 2014). In budding yeast 
cells, Trm112 is required for the stability of Bud23 and Mtq2, but not for 
Trm11, Nop2, and Rcm1 (Sardana and Johnson, 2012). The interaction mode of 
other complexes (Trm11-Trm112, Mtq2-Trm112, and Trm9-Trm112 hetero-
dimers) is similar to the Bud23-Trm112 complex and only the tRNA methyl-
transferase Trm11 can be expressed and purified in E. coli without Trm112 co-
expression (Bourgeois et al., 2017b).  
 
 
5.2.3. WBSCR22 regulates the subcellular localization of TRMT112 
We and others have previously shown by indirect immunofluorescence analysis 
that endogenous WBSCR22 localizes diffusely in the cell nucleus (Paper I, Fig. 
5A; Nakazawa et al., 2011; Zorbas et al., 2015). In silico predictions indicate 
that ~50% of human TRMT112 protein localizes to the cytoplasm (Towns and 
Begley, 2012). In accordance with this, indirect immunofluorescence analyses 
reveal that human TRMT112 distributes to both the nucleus and the cytoplasm 
of HeLa cells, and, moreover, is excluded from the nucleolus (Paper II, Fig. 
S1). In another publication, human TRMT112 was found to be enriched in the 
nucleus and excluded from the nucleoli, with only a fraction of the protein 
found in the cytoplasm (Zorbas et al., 2015). Comparing the work of our group 
and D. Lafontaine’s group, the sub-nuclear distribution of TRMT112 protein is 
identical; however, the amount and distribution of cytoplasmic TRMT112 
protein is different. The same antibody against human TRMT112 protein as in 
our work was also used for the Human Protein Atlas database; however, in their 
work, TRMT112 protein co-localizes with microtubules, while only a small 
fraction of the protein is nuclear (Uhlén et al., 2015). Thus, the results of 
different groups are in partial disagreement and, therefore, the use of another 
method for studying the subcellular localization of TRMT112 would be 
beneficial. In order to further examine the subcellular distribution of TRMT112, 
a construct that encodes the fluorescent fusion protein TRMT112-mCherry was 
generated. As demonstrated in Fig. 3A of Paper II, the control protein mCherry 
and TRMT112-mCherry can be detected throughout the entire cell, both in the 
nucleus and in the cytoplasm. These data are in agreement with immuno-
fluorescence analysis of the TRMT112 protein and indicate that TRMT112 can 
shuttle between the nucleus and cytoplasm of the cell.  
In order to analyse the subcellular distribution of the WBSCR22 and 
TRMT112 complex, EGFP-WBSCR22 and TRMT112-mCherry fusion proteins 
were co-expressed in human cells and analysed using live cell microscopy. The 
fluorescence signals of EGFP-WBSCR22 and TRMT112-mCherry were detected 
in the cell nucleus, indicating that WBSCR22-TRMT112 complex localizes 
mainly in nucleoplasm (Paper II, Fig. 3B). When WBSCR22 is exogenously 
expressed together with TRMT112, the latter protein redistributes to the cell 
nucleus, thereby implying that WBSCR22 affects the subcellular localization of 
TRMT112. However, while TRMT112-mCherry in complex with EGFP-
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WBSCR22 can be detected in the nucleolus it does not display enrichment 
towards this compartment. 
Based on co-immunoprecipitation analysis, WBSCR22 interacts with 
TRMT112 via its N-terminal methyltransferase domain (MTD) (Paper II, Fig. 
3D). The fusion protein EGFP-WBSCR22-MTD, which lacks the C-terminally 
located NLS, localizes within the cytoplasm of HeLa cells, and, crucially, when 
co-expressed with TRMT112-mCherry, both proteins localize within the 
cytoplasm (Paper II, Fig. 3B). On the other hand, the chimeric protein EGFP-
WBSCR22-CTD, which is comprised of the EGFP protein fused with 38 amino 
acids from the C-terminus of WBSCR22, does not interact with TRMT112 
(Paper II, Fig. 3E). In agreement with the other experiments, co-expression of 
EGFP-WBSCR22-CTD and TRMT112-mCherry does not change the sub-
cellular localization of the latter protein – EGFP-WBSCR22-CTD is a nuclear 
protein that is enriched in the nucleoli, whereas in the same cells, TRMT112-
mCherry can be detected in the cytoplasm and nucleus of the cell and is 
excluded from the nucleoli (Paper II, Fig. 3B). These results demonstrate that 
the methyltransferase domain of WBSCR22 protein is important for its 
interaction with TRMT112, and, furthermore, the localization of the WBSCR22-
TRMT112 complex is determined by the WBSCR22 protein. 
 
 
5.2.4. WBSCR22 mutants defective in TRMT112 binding  
are less stable than the wild-type protein 
In order to gain more knowledge about the biological function of the WBSCR22-
TRMT112 interaction, WBSCR22 mutants with substitutions in amino acids 
located on the interface of the WBSCR22-TRMT112 complex were generated. 
A crystal structure analysis of the budding yeast Bud23-Trm112 complex 
indicates that the interaction interface consists of a large hydrophobic core 
surrounded by polar residues (Létoquart et al., 2014). A sequence alignment 
between Bud23 and WBSCR22 proteins demonstrates that the amino acid 
residues involved in complex formation are conserved between budding yeast 
and human (Létoquart et al., 2014).  
Based on the conservation data, two putative TRMT112 binding deficient 
mutants of WBSCR22 protein – WBSCR22-KT/AA and WBSCR22-D117A – 
were constructed in the current work (Paper II). In the WBSCR22-D117A 
mutant, the conserved aspartic acid at position 117 of WBSCR22 is replaced 
with alanine, and in the WBSCR22-KT/AA double-mutant, the lysine and 
threonine at positions 112 and 115, respectively, are replaced with alanines. In 
addition, these mutants contained either an E2Tag epitope tag in their  
N-terminus or were expressed as fusion proteins in-frame with EGFP. 
The amino acid D112 of Bud23, corresponding to D117 in WBSCR22, is 
involved in the formation of a salt bridges between Bud23 and Trm112, and the 
Bud23 D112A and D112G mutants exhibit a slow-growth phenotype (Létoquart 
et al., 2014). The amino acids R107 and S110 of Bud23 are both involved in the 
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formation of hydrogen bonds in the Bud23-Trm112 complex, and correspond to 
K112 and T115 in the WBSCR22 protein (Létoquart et al., 2014). As shown by 
two hybrid assays in yeast, single-mutant R107L, S110P, and D112G forms of 
Bud23, as well as triple-mutant Bud23, have reduced binding to Trm112 (Sardana 
and Johnson, 2012; Sardana et al., 2014). Much less is known about the inter-
action between human WBSCR22 and TRMT112 proteins. 
With the aim of tracking the expression of the WBSCR22 protein variants 
described above, HeLa cells were transiently transfected with plasmids that either 
encode for EGFP-WBSCR22, or one of its mutants KT/AA and D117A, and the 
number of EGFP positive cells was monitored up to three days after transfection 
using flow cytometry analysis. As shown in Fig. 4A of Paper II, 24 hours after 
transfection approximately 50% of the cells expressed the EGFP and EGFP-
WBSCR22 proteins, whereas only about 40% of the cells expressed the mutant 
proteins EGFP-WBSCR22-D117A and EGFP-WBSCR22-KT/AA. After 48 
hours, the percentage of cells expressing EGFP and EGFP-WBSCR22 proteins 
was still close to 50%, whereas the number of cells expressing mutant proteins 
EGFP-WBSCR22-D117A and EGFP-WBSCR22-KT/AA had declined to 15–
20%. 72 hours after transfection, the difference between WBSCR22 and its 
mutants was even more pronounced. Similar results were seen in other human 
cell lines. 
The expression of WBSCR22 protein and its mutants using flow cytometry 
was also confirmed using immunoblot analysis. For this experiment, the epitope-
tagged WBSCR22 protein was expressed in HeLa cells, which were lysed 24 
hours after transfection. As seen in Fig. 4B of Paper II, the expression level of 
wild-type WBSCR22 protein was elevated compared to the mutant proteins 
WBSCR22-KT/AA and D117A, which were barely detectable. The ectopic 
expression of epitope-tagged TRMT112 protein increased the abundance of 
wild-type WBSCR22 protein as well as the expression levels of the mutant 
proteins, which indicates that the mutants have possibly retained some ability to 
bind to TRMT112. Nevertheless, over-expression of TRMT112 had more 
influence on the protein level of wild-type WBSCR22 protein compared to its 
impact on the expression levels of the WBSCR22 mutants. The protein level of 
TRMT112 was also increased by co-expression with WBSCR22, indicating that 
WBSCR22 and TRMT112 proteins stabilize each other within the cells.  
In order to investigate how strongly the WBSCR22 point-mutations affect 
the interaction with TRMT112 protein, a co-immunoprecipitation analysis was 
performed in HeLa cells. Epitope-tagged wild-type WBSCR22 protein was able 
to pull-down the endogenous TRMT112 protein (Paper II, Fig. 4C), and, 
reciprocally, epitope-tagged TRMT112 co-immunoprecipitated with the endo-
genous WBSCR22 protein (Paper II, Fig. 4D). Unfortunately, due to the low 
expression levels of the WBSCR22 mutants in HeLa cells, the results of the 
pull-down experiments did not provide insight into whether the interaction with 
TRMT112 was affected in these cells. Therefore, a similar co-immuno-
precipitation analysis was performed in COS-7 cells. COS-7 cells express the 
large T-antigen of simian virus 40 (SV40), allowing plasmids containing the 
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SV40 origin of replication to replicate in these cells, thereby augmenting the 
level of plasmid-driven gene expression. The vector that encodes EGFP protein 
replicates in COS-7 cells (Paper II, Fig. 4A) and the expression levels of 
WBSCR22 protein and its mutants are high in COS-7 cells (Paper II, Fig. 4E). 
Furthermore, the number of cells expressing EGFP-WBSCR22 and its mutant 
variants remained constant for three days (Paper II, Fig 4A). Fig. 4E within 
Paper II shows that the wild-type WBSCR22 protein and also both mutants 
(KT/AA and D117A) were able to pull-down endogenous TRMT112 protein. 
However, the resulting amount of TRMT112 protein was different between 
WBSCR22 and its mutants. Mutating WBSCR22 lysine 112 and threonine 115 
results in about a 2-fold decrease of co-precipitated TRMT112, while mutating 
the highly conserved aspartic acid 117 results in an almost complete loss of 
interaction between WBSCR22 and TRMT112. This confirms that the residues 
K112, T115, and D117 within WBSCR22 are all important for interacting with 
TRMT112.  
The subcellular localization of EGFP-WBSCR22-D117A is similar to the 
wild-type protein, i.e., the D117A mutant localises to the nucleus and nucleoli 
(Paper II, Fig. 3B). Surprisingly, the co-expression of EGFP-WBSCR22-D117A 
and TRMT112-mCherry caused an enrichment of TRMT112-mCherry in the 
nucleus. This result points to the possibility that the nuclear accumulation of 
TRMT112-mCherry is caused by endogenous WBSCR22 protein. In support of 
this, the depletion of endogenous WBSCR22 by RNA interference decreased 
the amount of WBSCR22-D117A and TRMT112 in the nucleus and increased the 
amount of cytoplasmic TRMT112-mCherry (Paper II, Fig. S2). Nevertheless, 
these results indicate that the WBSCR22-D117A mutant has retained some 
ability to bind to TRMT112. 
 
 
5.2.5. The level of WBSCR22 protein is regulated  
by the ubiquitin-proteasome pathway 
The stability of WBSCR22 protein is controlled by its interaction partner 
TRMT112, and WBSCR22 mutants with reduced affinity towards TRMT112 
are less stable than wild-type WBSCR22. Furthermore, ectopically expressed 
EGFP-WBSCR22 wild-type seems to be less stable than the control protein 
EGFP. In eukaryotic cells, the turnover of cellular proteins is chiefly regulated 
by the ubiquitin-proteasome pathway. In order to find out whether the amount 
of WBSCR22 protein and its mutants are controlled by proteasomal degra-
dation, HeLa cells were transfected with plasmids encode for EGFP, EGFP-
WBSCR22, and its mutants, and the number of cells expressing EGFP was 
monitored in the presence and absence of MG132, an inhibitor of the protea-
some. MG132 was added to the cells 24 hours after transfection, and cells were 
subsequently incubated for 16 hours before analysis by flow cytometry (Paper 
II, Fig. 6A). Inhibition of the ubiquitin-proteasome pathway slightly increased 
the percentage of cells expressing EGFP-WBSCR22; however, the proportion 
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of cells expressing EGFP protein did not change. The percentage of cells 
expressing EGFP-WBSCR22-D117A and EGFP-WBSCR22-KT/AA increased 
to the level of wild-type WBSCR22. These results indicate that the turnover of 
wild-type WBSCR22 as well as its mutants is regulated by proteasomal de-
gradation. Immunoblot analysis confirmed that the inhibition of proteasomes 
with MG132 increased the amount of ectopically expressed WBSCR22, whereas 
the amount of endogenous tubulin did not change (Paper II, Fig. 6B). In the same 
experiment, a slight increase in the expression level of endogenous TRMT112 
protein was also detected, implying that the degradation of TRMT112 protein is 
also under the control of the ubiquitin-proteasome pathway. As shown in Fig. 
6C within Paper II, the downregulation of TRMT112 expression decreased the 
amount of WBSCR22 protein, whereas the inhibition of proteasomes is able to 
increase the amount of WBSCR22 in TRMT112-depleted cells. This indicates 
that unbound WBSCR22 is degraded by the ubiquitin-proteasome pathway.  
Proteasome-dependent degradation involves the addition of poly-ubiquitin 
chains to the target molecule. In order to study whether ubiquitin chains are 
added to WBSCR22 protein, a co-immunoprecipitation experiment was per-
formed. In this experiment, HeLa cells were transfected with plasmids that 
encode HA-tagged ubiquitin and E2-tagged WBSCR22, and the antibody 
against E2 Tag was used to precipitate WBSCR22 complexes. As shown in Fig. 
6D within Paper II, WBSCR22 and WBSCR22-D17A pull-down fractions 
contained poly-ubiquitinylated molecules, which again confirm that the amount 
of WBSCR22 is controlled by proteasome-dependent degradation. 
 
 
5.2.6. WBSCR22 complements the growth and ribosome  
biogenesis defect of budding yeast ΔBud23 mutant strain 
The budding yeast ∆Bud23 strain is characterized by a slow grow growth 
phenotype, which is caused by defects in ribosome biogenesis and pre-rRNA 
processing (White et al., 2008). The human WBSCR22 protein is also involved 
in the formation of 18S rRNA and the ribosome small subunit, and the decreased 
expression of WBSCR22 protein also affects the rate of cell growth (Paper I, 
Fig. 1 and 2). In order to investigate whether the functions of these two proteins 
are conserved, a complementation experiment was performed in the ∆Bud23 
yeast strain. As demonstrated in Paper I, Fig. 4A, the expression of the budding 
yeast protein Bud23 is able to restore a normal growth phenotype and defects in 
ribosome biogenesis. The expression of WBSCR22 protein in this yeast strain 
partially complements both defects, which indicates that the function of human 
WBSCR22 and budding yeast Bud23 are conserved, at least in part. In 
comparison, others have shown that the expression of wild-type RID2 protein of 
Arabidopsis thaliana does not rescue the slow growth phenotype of ∆Bud23 
(Ohbayashi et al., 2011). Compared to the negative control, the expression of 
WBSCR22 mutants D117A and KT/AA also enhanced the slow growth of 
∆Bud23, although to a much lesser extent than the expression of wild-type 
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WBSCR22 (Paper II, Fig. 5A). Further, the expression of WBSCR22 mutants 
with reduced TRMT112 binding is not able to restore the ribosome biogenesis 
defects of ∆Bud23 (Paper II, Fig. 5B). These mutants may have lost the ability 
to bind yeast Trm112, which can reduce their stability in yeast cells in a similar 
manner to what was observed in human cells. 
 
 
5.3. Ribosomal proteins and tRNA synthetases  
are incorporated into MLV Gag induced  
extracellular vesicles (Paper III) 
Recombinant virus-like particles (VLPs) can be used to transfer biological 
information between cells and tissues. In the second part of this dissertation, the 
protein content of retrovirus Gag protein induced VLPs was analysed. This 
information is important to avoid unwanted side-effects, when using these VLPs 
in biological systems. This work is part of a larger project that aimed to produce 
VLPs that express melanoma antigens with the purpose of using them for 
immunotherapy of melanoma patients.  
In mammalian cells, the expression of retroviral Gag protein causes the 
spontaneous formation and release of virus-like particles to the tissue culture 
media (Larson et al., 2005). In the current work, the budding properties of Gag 
protein of murine leukemia virus (MLV) were used to produce a family of 
chimeric VLPs that each carry one of the following cancer/testis antigens: 
MART1, TRP1, MAGEA4, MAGEA10, or MCAM. The results of dynamic 
light scattering and transmission electron microscopy experiments indicate that 
the average size of MLV Gag VLPs is ~140 nm and the size of VLPs that carry 
melanoma antigens are very similar to each other. The assembled particles have 
a spherical structure and regular shape.  
In order to characterize the protein content of Gag VLPs and VLPs carrying 
melanoma antigens, LC-MS/MS-based label-free quantitative proteomics analysis 
was performed. The results of these proteomics tests are presented in Supple-
mentary Dataset 1 and in Fig. 5 within Paper III. The results indicate that all six 
types of VLPs contained the MLV Gag protei, and in addition, the melanoma 
antigens were incorporated into their respective VLPs. An immunoblot analysis 
of the MLV Gag protein further confirms that this protein is included in all 
particles (Paper III, Fig. 5E). However, in addition to exogenously expressed 
proteins, the mass-spectrometry analysis enabled to detect that VLPs contained 
more than 500 proteins acquired from the host cells. Probably, most of these 
cellular proteins are encapsulated into VLPs. Nonetheless, some of the cellular 
proteins might bind to the surface of VLPs after the assembly of VLPs.  
In order to better understand which proteins form the components of these 
VLPs, the identified cellular proteins were divided into several classes based on 
their function. Among the proteins identified by LC-MS/MS analysis were 
Tsg101, Alix, and Nedd4, which are all proteins that directly interact with MLV 
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Gag protein and are involved in the budding of VLPs (Segura-Morales et al., 
2005). Tsg101 and Alix are components of extracellular vesicles and are 
considered as markers of exosomes (Colombo et al., 2014). In addition, all VLPs 
contained the clathrin adaptor complex subunit AP-1, which is involved in 
retroviral release (Camus et al., 2007).  
In addition to proteins that facilitate the budding of particles, these VLPs 
contained cellular proteins from various groups, including cell adhesion, 
membrane and cytoskeleton proteins, ribosomal proteins, translation factors, 
tRNA synthetases, metabolic enzymes, RNA binding proteins, and RNA heli-
cases. The results of immunoblot analyses (Paper III, Fig. 5E) support these 
LC-MS/MS findings and demonstrate that cytoskeleton protein α-tubulin and 
ribosomal protein Rps6 are components of the MLV Gag based VLPs. Others 
have also reported that ribosomal proteins and rRNA can be incorporated into 
MLV VLPs (Muriaux et al., 2002); however, the significance of incorporating 
components of translational machinery (e.g., ribosomal proteins, tRNA synthe-
tases, and translation factors) into VLPs remains unknown. Mutations in the 
MLV Gag protein cause the assembly of immature particles, where the viral 
genomic RNA is replaced with ribosomal RNA (Muriaux et al., 2002). These 
authors suggest that intact ribosomes or ribosomal subunits are packaged into 
the VLPs (Muriaux et al., 2002). Similarly, other proteomic characterizations of 
endogenous extracellular vesicles demonstrate that both microvesicles and 
exosomes contain ribosomal proteins and other proteins involved in translation 
(Kowal et al., 2016; Willms et al., 2016). The majority of proteins found in the 
exosomes of neuroblastoma cells are either cytoplasmic (~40%) or membrane 
proteins (~16%) (Marimpietri et al., 2013). It is possible that ribosomal proteins 
that naturally locate within the cytoplasm are passively incorporated into VLPs 
and other types of EVs. To support this, a comparison of the proteome of host 
cell membrane and HIV Gag induced particles found that the protein 
composition of VLPs and the plasma membrane is similar and the bulk of the 
host proteins in the plasma membrane are passively incorporated into the VLPs 
(Hammarstedt and Garoff, 2004).  
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6. CONCLUSIONS 
Based on the results of Paper I and Paper II presented in the first part of this 
dissertation, the following conclusions can be made: 
• The expression level of WBSCR22 protein is decreased in cell lines derived 
from Williams-Beuren syndrome patients. This result is in agreement with a 
reduced level of WBSCR22 mRNA in these cells.  
• WBSCR22 is a nuclear protein that exhibits a diffuse signal throughout the 
nucleoplasm in human cells. When overexpressed, some of the WBSCR22 
protein accumulates within the nucleoli, which reveals that WBSCR22 might 
have an affinity to bind with pre-ribosomes.  
• WBSCR22 is important for cell growth, ribosome small subunit biogenesis, 
and pre-rRNA processing. Depletion of WBSCR22 causes the nuclear 
accumulation of the last precursor of 18S rRNA, the 18S-E pre-rRNA, 
thereby leading to reduced production of mature 18S rRNA and ribosomal 
40S subunits.  
• WBSCR22 interacts with TRMT112 protein in human cells and this 
interaction is important for the stability of WBSCR22 protein. 
• The subcellular localization of WBSCR22-TRMT112 complexes are 
determined by WBSCR22.  
• The expression level of WBSCR22 protein is tightly controlled. Under 
normal conditions, WBSCR22 protein is either bound to TRMT112 in the 
nucleoplasm or localizes to nucleolus where it may be associated with 
nucleolar proteins or rRNA. Under these conditions, when the amount of 
TRMT112 is limited, e.g., WBSCR22 is overexpressed or the expression 
level of TRMT112 is decreased, unbound WBSCR22 is tagged with ubi-
quitin and degraded by the 26S ubiquitin-proteasome pathway. 
 
The results of the second part of this dissertation enabled to conclude that virus-
like particles, induced by the exogenous expression of murine leukemia virus 
Gag protein, contain several groups of cellular proteins, including ribosomal 
proteins, tRNA synthetases, and translation initiation factors. It is currently 
unknown whether the incorporation of ribosomal proteins into VLPs are 





SUMMARY IN ESTONIAN 
Williams-Beureni sündroomi kromosoomiregiooni valk WBSCR22  
kui ribosoomi biogeneesifaktor 
Ribosoomide biogenees on kompleksne protsess, milles osaleb ligi 300 valku 
ning neist valkudest umbes kolmandik on seotud genoomsete haiguste ja kasva-
jate tekkega. Williams-Beureni sündroom (WBS) on multisüsteemne arengu-
häire, mida põhjustab on umbes 30 geeni puudumine seitsmenda kromosoomi 
pikast õlast, lookusest 7q11.23. WBS patsientidel esineb rida erinevaid prob-
leeme, millest kõige sagedasemateks on kaasasündinud südame-veresoonkonna 
haigused, aga ka sidekoe arenguhäired, neuroloogilised probleemid, spetsiifiline 
kognitiivne profiil, kasvuprobleemid ja iseloomulikud näojooned. Genoomsed 
ümberkorraldused nagu deletsioonid, duplikatsioonid ja inversioonid WBS 
kromosoomiregioonis tekivad selle genoomipiirkonna kompleksuse tõttu. 
Nimelt ümbritsevad 7q11.23 piirkonna geenidega ala madalakoopiaarvulised 
kordusjärjestused, mis oma kõrge sarnasuse tõttu põhjustavad valepaardumisest 
tingitud ümberkorraldusi. Ehkki mehhanismid, mis viivad 7q11.23 piirkonna 
genoomsete häirete tekkimiseni, on suhteliselt hästi iseloomustatud, on vähem 
teada, kuidas üksikute geenide koopiaarvu muutus ja sellest tulenev avaldumis-
taseme erinevus põhjustab haigustunnuseid. Hetkel arvatakse, et paljud geenid 
on olulised WBS-i ning sama piirkonna duplikatsioonisündroomi kujunemisel, 
mistõttu on vajalik nendelt geenidelt ekspresseerivate valkude funktsioonide 
uurimine. Üheks WBS lookusest ekspresseeritavaks valguks, mille funktsioon 
enne antud doktoritöö tegemist oli teadmata, on WBSCR22. Nimetatud valgu 
iseloomustamine on oluline ka seetõttu, et on näidatud tema kõrget avaldumis-
taset mitmete kasvajate korral ning on teada, et WBSCR22 on oluline kasvaja-
rakkude elulemuse ja metastaatilise potentsiaali reguleermisel.  
Oma struktuurilt on WBSCR22 valk metüültransferaas ning bioinformaati-
liste meetoditega on talle ennustatud DNA metüleerimise aktiivsust. Uuritud on 
ka WBSCR22 valgu rolli histoonide metüleerijana, kuid alles hiljuti avastati, et 
tegelikult on WBSCR22 ensüüm, mis katalüüsib 18S ribosomaalse RNA (18S 
rRNA) metüleerimist. Antud doktoritöö esimese ning peamise osa eesmärgiks 
oli WBSCR22 funktsiooni uurimine imetaja rakkudes.  
Antud töö raames leiti, et WBSCR22 valk asub hajusalt rakutuumas, kuid 
tema kõrgema avaldumistaseme juures on näha valgu kogunemist tuumakesse. 
Selles tuumasiseses struktuuris toimub rRNA süntees ja algab ribosoomide 
biogenees. WBSCR22 valgu paiknemine tuumakeses viitab, et ta võib seonduda 
varajaste pre-ribosoomidega. Eukarüootide ribosoomide biogenees hõlmab pre-
rRNA ja ribosoomivalkude sünteesimist, pre-rRNA protsessimist, rRNA-de 
modifitseerimist, ribosoomi subühikute kokkupanemist, nende eksoprti tuumast 
tsütoplasmasse ning sünteesitavate ribosoomide kvaliteedi kontrollimist. Antud 
doktoritöös leiti, et WBSCR22 on oluline rakkude jagunemiseks, ribosoomi 
väikese subühiku biogeneesil ja pre-rRNA protsessingul. Täpsemalt, WBSCR22 
ekspressiooni mahasurumine põhjustab 18S-E pre-rRNA kuhjumist raku tuumas. 
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18S-E pre-rRNA on viimane 18S rRNA eellane, mida leidub nii raku tuumas kui 
tsütoplasmas. Pärast 18S-E pre-rRNA eksporti toimub tema viimane endoribo-
nuklelüütiline lõikamine, mille tulemusel moodustub küps 18S rRNA. 
WBSCR22 valgu avaldumistaseme vähenemine toob kaasa 18S rRNA hulga 
languse tsütoplasmas, mistõttu pärsitakse ribosoomi 40S subühikute teke ning 
see omakorda võib põhjustada rakkude aeglasemat jagunemist. 
Selleks et uurida, millised on WBSCR22 valgu interaktsioonipartnerid, 
konstrueeriti inimese rakuliin, mis püsivalt tootis epitoopmärgisega WBSCR22 
valku ning leiti, et üheks WBSCR22-ga seonduvaks valguks on TRMT112. 
Lisaks näidati, et TRMT112 paiknemine rakus on määratud WBSCR22 poolt, 
WBSCR22-TRMT112 kompleks paikneb raku tuumas ning WBSCR22-
TRMT112 kompleksi teke on vajalik WBSCR22 stabiilsuse tagamiseks. 
WBSCR22 valgu hulk rakus on kontrollitud – tuumaplasmas on WBSCR22 
seotud TRMT112-ga ning tuumakese piirkonnas ilmselt tuumakese valkude või 
rRNA-ga. Juhul kui rakkudes ei ole piisavalt TRMT112, näiteks WBSCR22 
üleekspressiooni või TRMT112 vaigistamise korral, siis WBSCR22 valk 
märgistatakse ubikvitiini molekulidega ja lagundatakse 26S proteasoomi rajas.  
Selle doktoritöö teises osas analüüsiti retroviiruste Gag valgu poolt 
indutseeritud viiruslaadsete partiklite (VLP-de) valgulist koostist ning avastati, 
et nendes VLP-des esineb suur hulk rakulisi valke, nende seas ka suur hulk 
ribosoomivalke. Paljude rakuliste valkude, sealhulgas ribosoomivalkude roll, 
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